https://curecurrent.com/trials/vaccine-therapy-and-pembrolizumab-in-treating-patients-with-solid-tumors-that-have-failed-prior-therapy-28001https://curecurrent.com/trials/converting-hr-breast-cancer-into-an-individualized-vaccine-28002https://curecurrent.com/trials/comparison-of-breast-sensory-recovery-between-conventional-and-endoscopic-nipple-sparing-mastectomy-combined-with-prepec-28003https://curecurrent.com/trials/catch-implementation-of-genomics-guided-precision-medicine-in-metastatic-breast-cancer-28004https://curecurrent.com/trials/impact-of-breast-cancer-on-human-folliculogenesis-28005https://curecurrent.com/trials/revive-replens-versus-intra-vaginal-estrogen-for-the-treatment-of-vaginal-dryness-on-aromatase-inhibitor-therapy-28006https://curecurrent.com/trials/evaluation-of-lasofoxifene-versus-fulvestrant-in-advanced-or-metastatic-er-her2-breast-cancer-with-an-esr1-mutation-28007https://curecurrent.com/trials/case-1320-rai-uptake-and-serum-prolactin-in-thyroid-cancer-28008https://curecurrent.com/trials/molecular-mechanisms-of-clinical-resistance-to-targeted-therapy-among-patients-with-breast-cancer-28009https://curecurrent.com/trials/multicenter-phase-ii-clinical-study-of-sacituzumab-tirumotecan-sac-tmt-in-combination-with-kl-a167-for-neoadjuvant-treat-28010https://curecurrent.com/trials/effects-of-mmv-exercise-with-and-without-verbal-guidance-on-shoulder-movement-fatigue-and-stress-in-breast-cancer-surviv-28011https://curecurrent.com/trials/dose-finding-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-snb-101-sn-38-in-patients-with-tumors-28012https://curecurrent.com/trials/no-axillary-surgery-in-early-breast-cancer-oxigenate-28013https://curecurrent.com/trials/a-non-interventional-study-for-women-with-hr-positive-her2-negative-locally-advanced-or-metastatic-breast-cancer-to-eval-28014https://curecurrent.com/trials/sapu003-in-advanced-mtor-sensitive-solid-tumors-28015https://curecurrent.com/trials/effect-of-esketamine-on-perioperative-negative-emotions-in-patients-undergoing-breast-cancer-surgery-28016https://curecurrent.com/trials/towards-understanding-between-adt-treatment-circadian-rhythm-and-physiological-responsiveness-28017https://curecurrent.com/trials/time-restricted-eating-in-menopause-and-hormone-sensitive-breast-cancers-tremho-28018https://curecurrent.com/trials/pten-and-organ-specific-micrornas-in-metastatic-breast-cancer-28019https://curecurrent.com/trials/personalized-second-chance-breast-conservation-pscbc-a-prospective-phase-ii-clinical-study-28020https://curecurrent.com/trials/target-specific-immunopet-imaging-of-breast-cancer-28021https://curecurrent.com/trials/a-study-of-art4215-for-the-treatment-of-advanced-or-metastatic-solid-tumors-28022https://curecurrent.com/trials/rc48-combined-with-chemotherapy-in-her2-positive-advanced-breast-cancer-patients-with-prior-top1i-adc-failure-28023https://curecurrent.com/trials/postoperative-pain-after-breast-surgery-under-tumescent-local-anaesthesia-versus-general-anaesthesia-tla-001-28024https://curecurrent.com/trials/combined-exercise-effects-in-breast-cancer-related-lymphedema-28025https://curecurrent.com/trials/neuromodulation-of-cardiovascular-risks-associated-with-cardiotoxic-chemotherapy-28026https://curecurrent.com/trials/the-influence-of-chemotherapy-on-position-sense-28027https://curecurrent.com/trials/management-of-low-risk-grade-i-and-ii-dcis-28028https://curecurrent.com/trials/dwibs-mri-an-adjunct-to-the-traditional-diagnostic-breast-imaging-evaluation-28029https://curecurrent.com/trials/personalized-vaccine-immunotherapy-in-combination-with-checkpoint-inhibitor-for-treatment-of-triple-negative-breast-canc-28030https://curecurrent.com/trials/randomized-trial-of-accelerated-partial-breast-irradiation-28031https://curecurrent.com/trials/study-on-the-cosmetic-outcome-and-safety-evaluation-of-3d-printed-biodegradable-biological-mesh-for-one-stage-breast-rec-28032https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-with-zirconium-89-89zr-trastuzumab-for-prediction-of-her2-targeted-therapy-effe-28033https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-in-participants-with-non-small-cell-lung-cancer-or-breast-cancer-28034https://curecurrent.com/trials/a-study-of-ly2835219-abemaciclib-in-combination-with-therapies-for-breast-cancer-that-has-spread-28035https://curecurrent.com/trials/project-soar-speaking-our-african-american-realities-awakenings-for-black-american-women-diagnosed-with-breast-cancer-28036https://curecurrent.com/trials/the-effect-on-attendance-of-an-sms-notification-prior-to-a-scheduled-screening-appointment-in-breastscreen-norway-28037https://curecurrent.com/trials/video-immunotherapy-a-new-approach-in-breast-cancer-treatment-28038https://curecurrent.com/trials/hypofractionation-with-simultaneous-integrated-boost-for-early-breast-cancer-28039https://curecurrent.com/trials/screening-and-care-for-fear-of-cancer-recurrence-in-patients-with-cancer-at-institut-curie-28040https://curecurrent.com/trials/interactive-survivorship-program-for-the-improvement-of-healthcare-resources-in-adolescent-and-young-adult-cancer-surviv-28041https://curecurrent.com/trials/a-real-world-study-of-indian-patients-with-advanced-breast-cancer-treated-with-ribociclib-28042https://curecurrent.com/trials/analysis-of-the-presence-and-cardiac-functional-effects-of-anti-nav1-5-autoantibodies-in-patients-with-metastatic-tumors-28043https://curecurrent.com/trials/radiotherapy-omission-in-low-risk-ductal-in-situ-carcinoma-breast-28044https://curecurrent.com/trials/hki-272-for-her2-positive-breast-cancer-and-brain-metastases-28045https://curecurrent.com/trials/trial-to-compare-mri-guided-precision-prone-irradiation-ppi-versus-ct-guided-breast-irradiation-28046https://curecurrent.com/trials/mindfulness-based-intervention-for-depressive-symptoms-sent-via-text-mindset-28047https://curecurrent.com/trials/corticosteroids-for-doxorubicin-liposome-induced-hand-foot-skin-reactions-28048https://curecurrent.com/trials/implementation-of-a-remission-consultation-in-the-management-of-patients-treated-for-localized-breast-cancer-28049https://curecurrent.com/trials/pre-operative-sabr-with-and-without-caloric-restriction-for-early-stage-breast-cancer-28050https://curecurrent.com/trials/breast-cancer-screening-digital-breast-tomosynthesis-versus-digital-2d-mammography-28051https://curecurrent.com/trials/docetaxel-chemotherapy-and-pembrolizumab-plus-interleukin-12-gene-therapy-in-triple-negative-breast-cancer-28052https://curecurrent.com/trials/niraparib-in-combination-with-trastuzumab-in-metastatic-her2-breast-cancer-28053https://curecurrent.com/trials/finding-sentinel-lymph-nodes-during-mastectomy-using-indocyanine-green-inigma-study-28054https://curecurrent.com/trials/the-effect-of-group-and-mobile-wellness-coaching-given-to-women-with-breast-cancer-on-the-disease-28055https://curecurrent.com/trials/f-tryptophan-pet-ct-in-human-cancers-28056https://curecurrent.com/trials/comparison-of-efficacy-of-regional-blocks-in-breast-surgeries-28057https://curecurrent.com/trials/radiation-therapy-boost-before-surgery-for-the-treatment-of-non-metastatic-breast-cancer-28058https://curecurrent.com/trials/study-to-assess-the-effect-of-oct-598-in-patients-with-advanced-solid-tumors-28059https://curecurrent.com/trials/a-study-of-bl-m07d1-versus-t-dm1-in-the-adjuvant-treatment-of-her2-positive-breast-cancer-with-residual-invasive-cancer-28060https://curecurrent.com/trials/efficacy-and-safety-of-trastuzumab-rezetecan-in-her2-expressing-breast-cancer-28061https://curecurrent.com/trials/impact-of-pectoral-versus-paravertebral-blocks-on-pain-and-physical-well-being-in-implant-based-breast-reconstruction-28062https://curecurrent.com/trials/pilot-study-of-veliparib-abt-888-and-lapatinib-tykerb-in-patients-with-metastatic-triple-negative-breast-cancer-28063https://curecurrent.com/trials/18f-f-gln-by-pet-ct-in-breast-cancer-28064https://curecurrent.com/trials/neratinib-fulvestrant-in-her2-er-metastatic-breast-cancer-28065https://curecurrent.com/trials/effect-on-body-movement-and-mental-skills-in-patients-who-received-gadolinium-based-contrast-media-for-magnetic-resonanc-28066https://curecurrent.com/trials/sacituzumab-govitecan-plus-bevacizumab-in-metastatic-tnbc-28067https://curecurrent.com/trials/trans-rosalee-study-a-biomarker-directed-translational-study-28068https://curecurrent.com/trials/breast-cancer-2-prevent-translational-center-of-excellence-tce-metastatic-markers-of-recurrent-tumor-phenotype-for-breas-28069https://curecurrent.com/trials/mirtazapine-for-acute-and-chronic-post-mastectomy-pain-28070https://curecurrent.com/trials/fda018-adc-vs-investigator-s-choice-chemotherapy-to-treat-locally-advanced-recurrent-or-metastatic-triple-negative-breas-28071https://curecurrent.com/trials/a-study-of-tak-500-with-or-without-pembrolizumab-in-adults-with-select-locally-advanced-or-metastatic-solid-tumors-28072https://curecurrent.com/trials/thrive-study-positive-affect-training-for-endocrine-therapy-medication-adherence-28073https://curecurrent.com/trials/tirzepatide-for-weight-loss-intervention-in-early-stage-hormone-receptor-positive-her2-negative-breast-cancer-28074https://curecurrent.com/trials/self-affirmation-intervention-after-mastectomy-28075https://curecurrent.com/trials/financial-toxicity-in-patients-with-early-stage-breast-cancer-28076https://curecurrent.com/trials/a-phase-1b-2-study-of-the-safety-and-efficacy-of-the-monoclonal-antibody-om-rca-01-in-patients-with-metastatic-tumors-ex-28077https://curecurrent.com/trials/adjuvant-regional-nodal-radiation-therapy-for-one-week-in-breast-cancer-28078https://curecurrent.com/trials/study-of-safety-and-efficacy-of-dky709-alone-or-in-combination-with-pdr001-in-patients-with-advanced-solid-tumors-28079https://curecurrent.com/trials/neoadjuvant-trastuzumab-rezetecan-plus-pertuzumab-or-nab-paclitaxel-carboplatin-trastuzumab-and-pyrotinib-after-suboptim-28080https://curecurrent.com/trials/pecs-ii-vs-mtp-for-analgesia-after-mrm-28081https://curecurrent.com/trials/investigating-the-metabolic-pathways-in-hormone-receptor-positive-her2-negative-breast-cancer-28082https://curecurrent.com/trials/a-self-monitoring-platform-for-tracking-medication-safety-and-concerns-in-cancer-patients-28083https://curecurrent.com/trials/cdk4-6-inhibitors-combined-with-standard-adjuvant-endocrine-therapy-in-high-risk-hr-her2-early-breast-cancer-patients-ch-28084https://curecurrent.com/trials/huaier-granule-and-proteinuria-28085https://curecurrent.com/trials/study-of-antivascular-therapy-combined-with-chemotherapy-versus-chemotherapy-in-adjuvant-therapy-of-tnbc-blis-patients-b-28086https://curecurrent.com/trials/assessing-the-response-rate-of-neo-adjuvant-taxotere-and-trastuzumab-in-nigerian-women-with-breast-cancer-28087https://curecurrent.com/trials/the-association-between-age-related-peripheral-blood-components-and-treatment-efficacy-in-breast-cancer-28088https://curecurrent.com/trials/testing-home-based-exercise-strategies-in-underserved-minority-cancer-patients-undergoing-chemotherapy-the-thrive-study-28089https://curecurrent.com/trials/radiofrequency-and-exercise-based-rehabilitation-on-symptoms-associated-with-pelvic-floor-dysfunctions-in-breast-cancer-28090https://curecurrent.com/trials/a-study-of-bl-m17d1-in-patients-with-locally-advanced-or-metastatic-her2-positive-negative-breast-cancer-and-other-solid-28091https://curecurrent.com/trials/a-study-of-gnc-077-in-patients-with-locally-advanced-or-metastatic-breast-cancer-and-other-solid-tumors-28092https://curecurrent.com/trials/a-study-of-bl-m07d1-versus-investigator-s-choice-of-chemotherapy-in-patients-with-her2-low-recurrent-metastatic-breast-c-28093https://curecurrent.com/trials/accuracy-of-sono-mammographic-features-in-molecular-classification-of-breast-cancer-28094https://curecurrent.com/trials/neoadjuvant-chemotherapy-combined-with-sintilimab-and-bevacizumab-for-tnbc-neotorch-breast07-28095https://curecurrent.com/trials/exactdna-003-nsabp-b-64-study-of-molecular-residual-disease-detection-in-breast-cancer-mrd-28096https://curecurrent.com/trials/longitudinal-tumor-burden-quantification-using-circulating-tumor-dna-in-metastatic-lobular-breast-cancer-28097https://curecurrent.com/trials/cfdna-assay-prospective-observational-validation-for-early-cancer-detection-and-minimal-residual-disease-28098https://curecurrent.com/trials/breast-cancer-locator-guided-vs-wire-localized-partial-mastectomy-for-breast-cancer-28099https://curecurrent.com/trials/study-assessing-the-potential-for-reduced-rates-of-implant-failure-using-multi-beam-intensity-modulated-radiation-therap-28100https://curecurrent.com/trials/68ga-pfa2-pet-imaging-for-the-diagnosis-of-annexin-a2-positive-tumors-28101https://curecurrent.com/trials/feasibility-of-symptom-management-for-patients-with-metastatic-breast-cancer-to-increase-exercise-28102https://curecurrent.com/trials/endoscopic-nipple-sparing-mastectomy-e-nsm-with-immediate-multistage-autologous-fat-grafting-imafg-for-total-breast-reco-28103https://curecurrent.com/trials/hand-and-foot-bath-for-taxane-induced-peripheral-neurotoxicity-28104https://curecurrent.com/trials/palbociclib-in-combination-with-tamoxifen-as-first-line-therapy-for-metastatic-hormone-receptor-positive-breast-cancer-28105https://curecurrent.com/trials/gene-signatures-to-guide-hr-mbc-therapy-in-a-diverse-cohort-28106https://curecurrent.com/trials/fluzoparib-as-adjuvant-treatment-in-patients-with-germline-homologous-recombination-repair-hrr-mutated-primary-breast-ca-28107https://curecurrent.com/trials/observation-of-the-effect-of-preoperative-use-of-dexmedetomidine-hydrochloride-nasal-spray-on-optimizing-awake-sedation-28108https://curecurrent.com/trials/genetically-informed-therapy-for-er-breast-cancer-post-cdk4-6-inhibitor-28109https://curecurrent.com/trials/social-risk-factors-and-discrimination-in-cancer-survivorship-28110https://curecurrent.com/trials/diet-modification-in-patients-with-luminal-early-breast-cancer-candidate-for-primary-surgery-28111https://curecurrent.com/trials/phase-iii-study-of-5tx-vs-15tx-of-rt-x-rays-or-protons-including-rni-in-breast-cancer-patients-28112https://curecurrent.com/trials/68-ga-fapi-46-pet-ct-for-the-diagnosis-of-metastatic-lesions-in-patients-with-lobular-breast-cancer-icl-28113https://curecurrent.com/trials/to-investigate-the-real-world-efficacy-and-safety-of-sacituzumab-govitecan-for-her2-negative-metastatic-breast-cancer-pa-28114https://curecurrent.com/trials/zetamet-bone-graft-in-the-repair-of-bone-defects-from-metastatic-breast-cancer-in-vertebral-bones-28115https://curecurrent.com/trials/analysis-of-pd-l1-tmb-msi-and-ctdna-dynamics-to-predict-and-monitor-response-to-immunotherapy-in-metastatic-cancer-28116https://curecurrent.com/trials/the-effect-of-a-health-belief-model-based-education-program-on-breast-self-examination-practice-behavior-breast-cancer-f-28117https://curecurrent.com/trials/supportive-effects-of-craniosacral-therapy-for-women-with-breast-cancer-28118https://curecurrent.com/trials/abbreviate-or-fast-breast-mri-for-supplemental-breast-cancer-screening-for-black-women-at-average-risk-and-dense-breasts-28119https://curecurrent.com/trials/validation-of-the-oncoliq-test-for-the-early-detection-of-breast-cancer-28120https://curecurrent.com/trials/sacituzumab-govitecan-pembrolizumab-in-hr-her2-mbc-28121https://curecurrent.com/trials/prospective-comparative-study-of-hypofractionated-adjuvant-radiotherapy-in-2-virsus-3-weeks-in-breast-cancer-28122https://curecurrent.com/trials/effect-of-hilotherapy-in-the-management-of-symptoms-related-to-taxane-associated-peripheral-neuropathy-28123https://curecurrent.com/trials/neoadjuvant-therapy-and-contrast-enhanced-mammography-for-early-stage-breast-cancer-28124https://curecurrent.com/trials/post-operative-radiotherapy-omission-in-selected-patients-with-early-breast-cancer-trial-international-version-prospecti-28125https://curecurrent.com/trials/acellular-dermal-matrix-surederm-bcs-in-breast-conserving-surgery-for-breast-cancer-patients-28126https://curecurrent.com/trials/development-of-a-multi-omics-prediction-model-for-immunotherapy-response-in-triple-negative-breast-cancer-subtypes-28127https://curecurrent.com/trials/multimodal-prehabilitation-program-that-combines-physical-exercise-psychological-intervention-and-nutritional-support-to-28128https://curecurrent.com/trials/sample-collection-for-ongoing-research-and-product-evaluation-study-28129https://curecurrent.com/trials/safety-and-efficacy-of-sph4336-in-combination-with-endocrine-therapy-in-the-treatment-of-locally-advanced-or-metastatic-28130https://curecurrent.com/trials/a-prospective-open-label-single-arm-exploratory-clinical-trial-to-evaluate-the-safety-and-tolerability-of-225ac-tr2205-i-28131https://curecurrent.com/trials/kansurvive-testing-a-model-for-improving-cancer-survivorship-care-in-rural-practice-28132https://curecurrent.com/trials/cell-free-dna-in-hereditary-and-high-risk-malignancies-1-28133https://curecurrent.com/trials/preoperative-endocrine-therapy-for-individualised-care-with-abemaciclib-28134https://curecurrent.com/trials/feasibility-and-effects-of-home-based-physical-activity-intervention-in-patients-with-breast-cancer-in-indonesia-28135https://curecurrent.com/trials/a-prospective-clinical-study-investigating-the-use-of-the-histolog-scanner-for-intraoperative-assessment-of-surgical-mar-28136https://curecurrent.com/trials/diagnostic-accuracy-of-carebot-ai-mmg-in-mammography-screening-multicenter-mrmc-study-28137https://curecurrent.com/trials/a-trial-of-itraconazole-effect-on-hrs-8080-pharmacokinetics-in-healthy-participants-28138https://curecurrent.com/trials/neoadjuvant-chemotherapy-combined-with-toripalimab-for-tnbc-neotorch-breast02-28139https://curecurrent.com/trials/artificial-intelligence-in-mammography-screening-in-norway-28140https://curecurrent.com/trials/the-sleep-after-breast-cancer-abc-study-examining-sleep-changes-and-biomarkers-among-breast-cancer-patients-28141https://curecurrent.com/trials/polyurethan-versus-non-polyurethan-covered-implants-in-combination-with-radiotherapy-28142https://curecurrent.com/trials/safety-and-efficacy-study-of-nuv-1511-in-adult-patients-with-advanced-solid-tumors-28143https://curecurrent.com/trials/patient-care-outreach-navigation-technology-and-support-2-0-28144https://curecurrent.com/trials/a-study-of-bl0175-injection-in-postmenopausal-female-adults-with-hr-positive-locally-advanced-or-metastatic-cancer-28145https://curecurrent.com/trials/levels-of-circulating-tumor-dna-as-a-predictive-marker-for-early-switch-in-treatment-for-patients-with-metastatic-stage-28146https://curecurrent.com/trials/a-study-to-compare-how-different-medicines-rosuvastatin-digoxin-metformin-and-furosemide-are-handled-by-the-body-of-heal-28147https://curecurrent.com/trials/study-assessing-the-efficacy-and-safety-of-alpelisib-plus-fulvestrant-or-letrozole-based-on-prior-endocrine-therapy-in-p-28148https://curecurrent.com/trials/a-prospective-study-of-hypothyroidism-after-radiotherapy-for-breast-cancer-28149https://curecurrent.com/trials/postmastecomy-internal-mammary-nodal-irradiation-for-high-risk-breast-cancer-patients-28150https://curecurrent.com/trials/decongestive-exercise-and-compression-for-breast-cancer-related-lymphedema-management-28151https://curecurrent.com/trials/jskn016-in-combination-with-d-0502-for-locally-advanced-or-metastatic-hr-positive-her2-negative-breast-cancer-28152https://curecurrent.com/trials/abbreviated-breast-mri-after-cancer-treatment-28153https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-pharmacokinetics-of-oc-001-in-patients-with-locally-advanced-or-metastatic-cancers-28154https://curecurrent.com/trials/vascular-supply-identification-lesion-extension-and-search-for-tumor-similarity-at-a-distance-by-vtm-in-breast-cancer-28155https://curecurrent.com/trials/randomized-study-of-hypofractionated-and-conventional-fractionation-radiotherapy-after-breast-conservative-surgery-28156https://curecurrent.com/trials/an-observational-real-world-study-to-evaluate-the-impact-of-dermatological-toxicities-on-the-quality-of-life-in-patients-28157https://curecurrent.com/trials/a-study-to-assess-the-effectiveness-of-trastuzumab-deruxtecan-in-chinese-breast-cancer-patients-refresh-28158https://curecurrent.com/trials/development-and-application-of-a-parenting-anxiety-intervention-program-for-young-and-middle-aged-female-breast-cancer-p-28159https://curecurrent.com/trials/bacterial-cellulose-monolaurin-hydrogel-for-acute-radiation-dermatitis-28160https://curecurrent.com/trials/study-to-compare-a-mono-atezolizumab-window-followed-by-a-atezolizumab-ctx-therapy-with-atezolizumab-ctx-therapy-28161https://curecurrent.com/trials/the-outcomes-of-fat-grafting-combined-with-latissimus-dorsi-muscle-flap-for-delayed-breast-reconstruction-after-mastecto-28162https://curecurrent.com/trials/assessement-of-potential-interest-of-68ga-ga-pentixafor-pet-ct-in-metastatic-triple-negative-breast-cancer-patients-28163https://curecurrent.com/trials/neratinib-combined-with-fulvestrant-and-eribulin-in-the-treatment-ofhr-her2-advanced-breast-cancer-28164https://curecurrent.com/trials/retrospective-observational-study-on-the-use-of-advanced-bacterial-binding-dressings-dacc-coated-hydrogel-dressings-in-r-28165https://curecurrent.com/trials/alopecia-prevention-scalp-cooling-in-chinese-breast-cancer-patients-28166https://curecurrent.com/trials/18f-iso-1-positron-emission-tomography-pet-ct-in-primary-breast-cancer-28167https://curecurrent.com/trials/a-phase-ii-clinical-study-evaluating-entinostat-with-or-without-anlotinib-fulvestrant-for-the-treatment-of-hormone-recep-28168https://curecurrent.com/trials/a-study-of-felmetatug-vedotin-sgn-b7h4v-in-advanced-solid-tumors-28169https://curecurrent.com/trials/evaluation-of-the-effect-of-using-ultrasound-robots-for-breast-cancer-screening-a-multicenter-parallel-group-cluster-ran-28170https://curecurrent.com/trials/clinical-study-of-hrs-8080-in-combination-with-dalpiciclib-isethionate-tablets-in-patients-with-unresectable-or-metastat-28171https://curecurrent.com/trials/real-world-clinical-outcomes-of-tucatinib-trastuzumab-and-capecitabine-following-trastuzumab-deruxtecan-t-dxd-for-the-tr-28172https://curecurrent.com/trials/effect-of-physical-training-program-on-the-exercise-adherence-for-breast-cancer-survivor-28173https://curecurrent.com/trials/hope-olaparib-palbociclib-and-fulvestrant-in-patients-with-brca-mutation-associated-hr-her2-metastatic-breast-cancer-28174https://curecurrent.com/trials/ultra-hypofractionated-vs-hypofractionated-radiation-for-node-positive-breast-cancer-28175https://curecurrent.com/trials/jab-2485-activity-in-adult-patients-with-advanced-solid-tumors-28176https://curecurrent.com/trials/breast-cancer-fitness-and-exercise-for-heart-health-the-be-fitter-study-28177https://curecurrent.com/trials/evaluating-the-dose-timing-morning-vs-evening-of-endocrine-therapy-and-its-effects-on-tolerability-and-compliance-28178https://curecurrent.com/trials/ql1706-for-the-neoadjuvant-treatment-of-hr-her2-breast-cancer-28179https://curecurrent.com/trials/nepa-in-patients-with-her2-positive-or-her2-low-advanced-breast-cancer-treated-with-t-dxd-28180https://curecurrent.com/trials/mri-guided-neoadjuvant-treatment-de-escalation-in-stage-ii-iii-tnbc-28181https://curecurrent.com/trials/role-of-preoperative-tapentadol-in-reduction-of-perioperative-analgesic-requirement-after-breast-conservative-surgery-in-28182https://curecurrent.com/trials/physical-rehabilitation-evaluation-and-optimal-physical-therapy-pre-opt-28183https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-tqb3616-in-combination-with-fulvestrant-versus-placebo-in-combination-with-fulves-28184https://curecurrent.com/trials/a-phase-ib-ii-study-to-evaluate-multiple-combination-therapies-of-fwd1802-in-patients-with-er-her2-bc-28185https://curecurrent.com/trials/ascertainment-of-peripheral-blood-or-saliva-samples-for-genetic-epidemiology-studies-of-familial-cancers-28186https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-pyrotinib-epirubicin-and-cyclophosphamide-followed-by-taxanes-and-trastuzumab-for-her-2-br-28187https://curecurrent.com/trials/a-phase-1-study-of-225ac-fpi-1434-injection-28188https://curecurrent.com/trials/collection-of-tissue-blood-and-cells-to-be-used-for-studying-the-causes-prevention-diagnosis-and-treatment-of-breast-can-28189https://curecurrent.com/trials/a-study-of-dr-0202-in-patients-with-locally-advanced-or-metastatic-relapsed-or-refractory-carcinomas-28190https://curecurrent.com/trials/a-study-of-lutetium-177lu-bl-arc001-in-patients-with-locally-advanced-or-metastatic-lung-cancer-breast-cancer-head-and-n-28191https://curecurrent.com/trials/rwe-about-qol-and-compliance-of-patients-with-ofs-in-china-28192https://curecurrent.com/trials/a-retrospective-analysis-of-robot-assisted-versus-endoscopic-breast-conserving-surgery-for-breast-cancer-28193https://curecurrent.com/trials/a-study-of-oral-loxo-292-selpercatinib-in-pediatric-participants-with-advanced-solid-or-primary-central-nervous-system-c-28194https://curecurrent.com/trials/a-study-of-safety-and-efficacy-of-kfa115-alone-and-in-combo-with-pembrolizumab-in-patients-with-select-advanced-cancers-28195https://curecurrent.com/trials/toxicity-markers-to-trastuzumab-deruxtecan-t-dxd-in-patients-with-advanced-breast-cancer-28196https://curecurrent.com/trials/sentinel-lymph-node-biopsy-after-neoadjuvant-chemotherapy-in-ibc-28197https://curecurrent.com/trials/omission-of-surgery-in-clinically-low-risk-her2positive-breast-cancer-with-high-her2-addiction-and-a-complete-response-f-28198https://curecurrent.com/trials/patient-experiences-with-the-covid-19-vaccination-after-breast-cancer-treatment-28199https://curecurrent.com/trials/freedom-resonance-for-early-detection-of-breast-cancer-metastases-28200https://curecurrent.com/trials/evaluation-of-a-cone-beam-ct-scanner-for-image-guided-radiotherapy-28201https://curecurrent.com/trials/pyrotinib-plus-neoadjuvant-chemotherapy-in-hr-her2-her4-high-breast-cancer-28202https://curecurrent.com/trials/percutaneous-cryoablation-of-low-risk-early-breast-cancer-28203https://curecurrent.com/trials/effects-of-white-button-mushroom-on-inflammation-in-obese-postmenopausal-women-at-high-risk-of-breast-cancer-28204https://curecurrent.com/trials/low-dose-tamoxifen-citrate-in-reducing-breast-cancer-risk-in-radiation-induced-cancer-survivors-28205https://curecurrent.com/trials/metformin-and-nightly-fasting-in-women-with-early-breast-cancer-28206https://curecurrent.com/trials/phase-ii-study-of-repotrectinib-with-or-without-fulvestrant-in-patients-with-hormone-receptor-positive-human-epidermal-g-28207https://curecurrent.com/trials/feasibility-and-acceptability-of-endoscopic-mastectomy-in-patients-with-breast-cancer-28208https://curecurrent.com/trials/research-on-new-methods-and-new-models-of-rehabilitation-intervention-for-cancer-patients-based-on-exercise-and-psycholo-28209https://curecurrent.com/trials/characterization-and-kinetic-of-chemotherapy-induced-cardiovascular-toxicity-in-breast-cancer-28210https://curecurrent.com/trials/comparison-between-er-loss-and-triple-negative-breast-cancer-guided-by-18f-fes-pet-ct-in-metastatic-breast-cancer-28211https://curecurrent.com/trials/prediction-of-radiotherapy-efficacy-in-patients-with-triple-negative-breast-cancer-28212https://curecurrent.com/trials/chemotherapy-with-or-without-adebrelimab-and-t-dxh-as-neoadjuvant-therapy-for-hr-her2-low-early-stage-breast-cancer-28213https://curecurrent.com/trials/a-study-to-compare-the-effectiveness-of-two-types-of-ultrasound-technologies-in-women-who-have-had-breast-cancer-28214https://curecurrent.com/trials/olaparib-in-metastatic-breast-cancer-28215https://curecurrent.com/trials/atezolizumab-and-chemotherapy-treatment-as-t-cell-activators-in-metastatic-triple-negative-breast-cancer-patients-28216https://curecurrent.com/trials/effects-of-a-single-chemotherapy-administration-on-skeletal-muscle-of-breast-cancer-patients-comparison-of-paclitaxel-vs-28217https://curecurrent.com/trials/incidence-of-dysgeusia-in-breast-cancer-patients-undergoing-chemotherapy-28218https://curecurrent.com/trials/alpelisib-byl719-in-combination-with-continued-endocrine-therapy-following-progression-on-endocrine-therapy-in-hormone-r-28219https://curecurrent.com/trials/neoadjuvant-dose-dense-chemotherapy-for-hr-her2-breast-cancer-patients-with-high-proliferation-index-28220https://curecurrent.com/trials/study-of-anxiety-after-a-session-of-energy-resonance-by-cutaneous-stimulation-28221https://curecurrent.com/trials/impact-of-adapted-physical-activity-on-cognitive-functions-in-breast-cancer-28222https://curecurrent.com/trials/study-of-pembrolizumab-plus-fulvestrant-in-hormone-receptor-positive-her-2-negative-advanced-metastatic-breast-cancer-pa-28223https://curecurrent.com/trials/radiological-prediction-of-response-to-neoadjuvant-chemoimmunotherapy-for-triple-negative-breast-cancer-28224https://curecurrent.com/trials/18f-fes-pet-ct-for-the-detection-of-distant-metastasis-in-low-grade-er-positive-stage-iii-breast-cancer-28225https://curecurrent.com/trials/ribociclib-and-bicalutamide-in-ar-tnbc-28226https://curecurrent.com/trials/a-study-on-tuvusertib-oral-atr-inhibitor-in-combination-with-plx038-topo1-inhibitor-in-patients-with-advanced-solid-tumo-28227https://curecurrent.com/trials/online-dietary-and-resistance-training-to-improve-physical-function-in-older-cancer-survivors-e-proof-trial-28228https://curecurrent.com/trials/analgesia-nociception-index-ani-after-unilateral-radical-mastectomy-as-an-evaluation-of-paravertebral-block-failure-28229https://curecurrent.com/trials/the-value-of-the-o-rads-radiological-classification-in-predicting-the-malignancy-of-ovarian-masses-in-children-28230https://curecurrent.com/trials/ffnp-pet-mr-imaging-of-progesterone-receptor-expression-in-invasive-breast-cancer-28231https://curecurrent.com/trials/influence-of-body-composition-on-chemotherapy-outcomes-in-localized-breast-cancer-28232https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-toxicities-of-plx038-in-patients-with-locally-advanced-or-metastatic-triple-negativ-28233https://curecurrent.com/trials/health-economic-evaluation-of-an-adapted-physical-activity-program-for-women-with-breast-cancer-28234https://curecurrent.com/trials/tucatinib-trastuzumab-and-capecitabine-with-srs-for-brain-metastases-from-her-2-positive-breast-cancer-28235https://curecurrent.com/trials/augmented-reality-feasibility-for-non-invasive-preoperative-tracking-in-breast-cancer-surgery-28236https://curecurrent.com/trials/efficacy-and-safety-of-trastuzumab-rezetecan-followed-by-cdk4-6-inhibitors-and-endocrine-therapy-in-hr-her2-low-ultra-lo-28237https://curecurrent.com/trials/effects-of-chemotherapy-treatment-on-metaboreflex-mechanoreflex-and-baroreflex-function-protect-08b-study-28238https://curecurrent.com/trials/oncoplastic-partial-mastectomy-with-intraoperative-radiation-therapy-iort-in-early-stage-breast-cancer-patients-with-pri-28239https://curecurrent.com/trials/a-multilevel-intervention-to-improve-timely-cancer-detection-and-treatment-initiation-28240https://curecurrent.com/trials/olinvacimab-with-pembrolizumab-in-patients-with-mtnbc-28241https://curecurrent.com/trials/hypofractionated-radiation-therapy-in-treating-patients-with-stage-0-iib-breast-cancer-28242https://curecurrent.com/trials/cellular-level-fluorescence-imaging-for-intraoperative-margin-assessment-in-breast-cancer-28243https://curecurrent.com/trials/prone-partial-breast-irradiation-pbi-a-prospective-randomized-trial-28244https://curecurrent.com/trials/this-clinical-trial-is-a-retrospective-multicenter-cohort-study-evaluating-the-real-world-characteristics-and-risk-of-di-28245https://curecurrent.com/trials/assessing-combined-sbrt-in-breast-cancer-non-responders-to-neoadjuvant-chemotherapy-28246https://curecurrent.com/trials/endocrine-therapy-base-on-21-gene-rs-28247https://curecurrent.com/trials/multiscale-omics-for-the-development-of-a-cohort-database-and-study-platform-in-breast-cancer-survivors-28248https://curecurrent.com/trials/prevention-of-symptomatic-skeletal-events-with-denosumab-administered-every-4-weeks-versus-every-12-weeks-28249https://curecurrent.com/trials/breast-cancer-pre-habilitation-and-prospective-surveillance-to-prevent-detect-and-optimize-physical-and-function-28250https://curecurrent.com/trials/neodoxy-targeting-breast-cancer-stem-cells-with-doxycycline-28251https://curecurrent.com/trials/validation-of-molecular-diagnostic-assays-to-detect-cancer-biomarkers-in-blood-primary-tumor-in-er-her2-mbc-28252https://curecurrent.com/trials/gabapentin-and-breast-surgery-decision-architecture-randomization-trial-gabs-dart-protocol-28253https://curecurrent.com/trials/trastuzumab-rezetecan-in-advanced-solid-tumors-refractory-to-standard-therapies-28254https://curecurrent.com/trials/a-randomised-open-label-multicentre-phase-iii-clinical-study-to-evaluate-the-efficacy-and-safety-of-js105-combined-with-28255https://curecurrent.com/trials/contrast-enhanced-ultrasound-for-sentinel-node-detection-28256https://curecurrent.com/trials/identification-of-sentinel-lymph-nodes-using-indocyanine-green-in-breast-cancer-patients-28257https://curecurrent.com/trials/arterial-stiffness-in-individuals-with-breast-cancer-28258https://curecurrent.com/trials/shr-a1811-plus-pertuzumab-as-neoadjuvant-therapy-for-early-or-locally-advanced-hr-positive-her2-positive-breast-cancer-a-28259https://curecurrent.com/trials/nutritional-supplements-complementary-alternative-medicine-by-prostate-breast-cancer-patients-28260https://curecurrent.com/trials/refining-local-regional-therapy-for-ibc-28261https://curecurrent.com/trials/comparing-sequential-neoadjuvant-treatment-including-chemotherapy-and-accelerated-radiation-focused-to-the-tumor-bed-vs-28262https://curecurrent.com/trials/68ga-fapi-pet-ct-evaluation-of-axillary-lymph-node-status-after-neoadjuvant-therapy-in-patients-with-clinical-axillary-l-28263https://curecurrent.com/trials/a-first-in-human-phase-1-study-of-jab-3312-in-adult-patients-with-advanced-solid-tumors-28264https://curecurrent.com/trials/sarcopenia-and-paclitaxel-induced-neuropathy-in-early-stage-breast-cancer-neuro-sarc-28265https://curecurrent.com/trials/vitamin-c-on-acute-and-chronic-post-mastectomy-pain-28266https://curecurrent.com/trials/pet-imaging-of-two-vartumabs-in-patients-with-solid-tumors-28267https://curecurrent.com/trials/consensus-on-skin-care-in-breast-cancer-patients-28268https://curecurrent.com/trials/trial-to-evaluate-the-impact-of-various-behavioural-interventions-to-increase-mammography-uptake-among-singaporean-women-28269https://curecurrent.com/trials/clinical-study-of-shr-a1811-with-or-without-letrozole-in-neoadjuvant-therapy-for-early-stage-hr-positive-her2-low-breast-28270https://curecurrent.com/trials/functional-evaluation-after-breast-reconstruction-with-a-minimally-invasive-latissimus-dorsi-flap-following-radical-surg-28271https://curecurrent.com/trials/metabolism-circadian-rhythms-and-ovarian-function-28272https://curecurrent.com/trials/study-of-the-sexual-health-of-patients-treated-for-breast-cancer-and-followed-up-in-the-observatory-of-fertility-at-jean-28273https://curecurrent.com/trials/efficacy-and-safety-of-supervised-therapeutic-exercise-in-cancer-patients-with-and-without-concurrent-treatment-28274https://curecurrent.com/trials/a-study-of-atezolizumab-plus-nab-paclitaxel-in-the-treatment-of-unresectable-locally-advanced-or-metastatic-pd-l1-positi-28275https://curecurrent.com/trials/a-study-of-samuraciclib-in-combination-with-fulvestrant-in-metastatic-or-locally-advanced-breast-cancer-in-adult-partici-28276https://curecurrent.com/trials/coenzyme-q10-and-chemotherapeutic-toxicity-in-breast-cancer-patients-28277https://curecurrent.com/trials/nurse-led-mind-body-intervention-on-sexual-health-for-breast-cancer-survivors-28278https://curecurrent.com/trials/incidence-and-factors-affecting-the-development-and-outcome-of-post-mastectomy-pain-syndrome-28279https://curecurrent.com/trials/prospective-screening-for-breast-cancer-related-lymphedema-28280https://curecurrent.com/trials/effect-of-capivasertib-on-ctdna-in-er-positive-breast-cancer-28281https://curecurrent.com/trials/rage-inhibition-to-decrease-cardiotoxicity-in-women-with-early-breast-cancer-28282https://curecurrent.com/trials/real-world-study-of-biosimilar-trastuzumab-in-her2-positive-breast-cancer-28283https://curecurrent.com/trials/a-dose-escalation-and-dose-expansion-study-of-intratumoral-onm-501-alone-and-in-combination-with-cemiplimab-in-patients-28284https://curecurrent.com/trials/thrive-well-cancer-fdtn-exercise-creatine-supplementation-28285https://curecurrent.com/trials/fulvestrant-with-ribociclib-versus-physician-s-choice-treatments-recurred-after-completion-of-adjuvant-cyclin-dependent-28286https://curecurrent.com/trials/interest-of-circulating-tumor-dna-in-digestive-and-gynecologic-breast-cancer-28287https://curecurrent.com/trials/developing-and-evaluating-culturally-relevant-interventions-to-improve-breast-cancer-screening-28288https://curecurrent.com/trials/the-ohio-state-university-osu-screen-community-program-28289https://curecurrent.com/trials/prehabilitation-of-breast-cancer-related-lymphedema-28290https://curecurrent.com/trials/patritumab-deruxtecan-u3-1402-in-unresectable-locally-advanced-or-metastatic-breast-cancer-28291https://curecurrent.com/trials/study-assessing-qbs72s-for-treating-brain-metastases-28292https://curecurrent.com/trials/acupressure-for-aromatase-inhibitor-associated-musculoskeletal-symptoms-in-patients-with-breast-cancer-28293https://curecurrent.com/trials/comparison-of-the-efficacy-of-cryotherapy-combined-with-compression-in-preventing-neuropathy-28294https://curecurrent.com/trials/endoxifen-in-adults-with-hormone-receptor-positive-solid-tumors-28295https://curecurrent.com/trials/metabotyping-of-broccoli-microgreen-in-obese-breast-cancer-survivors-28296https://curecurrent.com/trials/brave-heart-breast-cancer-radiotherapy-using-active-breathing-coordinator-to-avoid-exposure-of-heart-28297https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-efficacy-and-indications-of-rp903-28298https://curecurrent.com/trials/an-exploratory-study-on-individualized-neoadjuvant-treatment-regimens-for-early-hr-her2-breast-cancer-28299https://curecurrent.com/trials/an-exploratory-study-of-pertuzumab-and-trastuzumab-in-combination-with-palbociclib-and-exemestane-as-neoadjuvant-therapy-28300https://curecurrent.com/trials/evaluating-whether-integration-of-prognostic-and-predictive-algorithms-into-routine-clinical-practice-effect-whether-onc-28301https://curecurrent.com/trials/study-of-pembrolizumab-and-mifepristone-in-patients-with-advanced-her2-negative-breast-cancer-28302https://curecurrent.com/trials/intraoperative-gamma-camera-for-breast-cancer-surgery-28303https://curecurrent.com/trials/selenoproteins-as-prognostic-markers-and-therapeutic-targets-in-breast-cancer-28304https://curecurrent.com/trials/pembrolizumab-with-carboplatin-compared-to-carboplatin-alone-in-breast-cancer-patients-with-chest-wall-disease-28305https://curecurrent.com/trials/breast-cancer-related-approach-for-increasing-cervical-cancer-screening-28306https://curecurrent.com/trials/sensitivity-of-organoids-to-predict-treatment-outcome-in-breast-cancer-metastases-28307https://curecurrent.com/trials/cdk-4-6-inhibitor-ribociclib-with-adjuvant-endocrine-therapy-for-er-positive-breast-cancer-28308https://curecurrent.com/trials/hyperthermia-and-olaparib-in-treating-breast-cancer-patients-with-chest-wall-recurrences-28309https://curecurrent.com/trials/prospective-pilot-study-of-robot-assisted-nipple-sparing-mastectomy-rnsm-28310https://curecurrent.com/trials/68ga-fapi-46-pet-ct-for-predicting-histological-response-in-triple-negative-breast-cancer-fap-it-28311https://curecurrent.com/trials/safety-and-feasibility-of-ire-for-early-stage-breast-cancer-a-prospective-open-label-single-arm-exploratory-study-28312https://curecurrent.com/trials/capivasertib-paclitaxel-as-first-line-treatment-for-patients-with-locally-advanced-or-metastatic-tnbc-28313https://curecurrent.com/trials/thermotherapy-in-addition-to-soc-palliative-radiotherapy-28314https://curecurrent.com/trials/endocrine-therapy-fulvestrant-palbociclib-or-aromatase-inhibitor-therapy-in-treating-older-patients-with-hormone-respons-28315https://curecurrent.com/trials/mindfulness-based-stress-reduction-mbsr-program-combined-with-endurance-exercise-training-a-help-in-treatment-for-breast-28316https://curecurrent.com/trials/ast-alt-mpv-platelets-ratios-in-breast-cancer-28317https://curecurrent.com/trials/elevate-an-elderly-breast-cancer-cohort-study-28318https://curecurrent.com/trials/extending-the-national-health-service-nhs-breast-screening-age-range-28319https://curecurrent.com/trials/bre-08-phase-ii-study-of-cmc-regimen-for-early-stage-breast-cancer-28320https://curecurrent.com/trials/screening-for-breast-cancer-with-digital-breast-tomosynthesis-28321https://curecurrent.com/trials/tailorx-tissue-bank-28322https://curecurrent.com/trials/eliminating-breast-surgery-for-breast-cancer-patients-with-clinical-complete-response-to-neoadjuvant-systemic-therapy-28323https://curecurrent.com/trials/mri-and-gene-expression-in-diagnosing-patients-with-ductal-breast-cancer-in-situ-28324https://curecurrent.com/trials/a-phase-ii-iii-clinical-study-to-evaluate-the-efficacy-and-safety-of-hlx87in-combination-with-hlx22-or-pertuzumab-in-the-28325https://curecurrent.com/trials/sentinel-lymph-node-biopsy-with-indocyanine-green-in-breast-cancer-after-neoadjuvant-chemotherapy-shine-28326https://curecurrent.com/trials/the-effect-of-acceptance-and-commitment-approach-based-psychoeducation-in-cancer-survivors-28327https://curecurrent.com/trials/breast-cancer-proteomics-and-molecular-heterogeneity-28328https://curecurrent.com/trials/de-convoluting-interactions-between-genes-the-cancer-environment-and-the-immune-system-to-develop-therapies-that-work-fo-28329https://curecurrent.com/trials/effect-of-virtual-reality-on-pain-and-anxiety-during-chemotherapy-session-in-breast-cancer-patients-28330https://curecurrent.com/trials/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-anti-her2-triple-targeted-drugs-combined-with-cdk4-6-inhibitors-28331https://curecurrent.com/trials/an-integrated-consent-model-study-to-compare-two-standard-of-care-schedules-for-monitoring-cardiac-function-in-patients-28332https://curecurrent.com/trials/a-clinical-trial-of-shr-a1811-in-the-treatment-of-triple-negative-breast-cancer-28333https://curecurrent.com/trials/prospective-registry-of-adc-as-first-and-second-line-treatment-for-breast-cancer-28334https://curecurrent.com/trials/registry-study-of-pregnancy-and-breast-cancer-28335https://curecurrent.com/trials/comparison-of-outcome-between-grisotti-flap-versus-reverse-mirror-grisotti-flap-for-central-quadrant-breast-tumors-28336https://curecurrent.com/trials/utilizing-mychart-to-assess-the-effectiveness-of-interventions-for-vasomotor-symptoms-a-feasibility-study-28337https://curecurrent.com/trials/mri-screening-for-brain-metastases-among-patients-with-triple-negative-or-her2-stage-ii-or-iii-breast-cancer-28338https://curecurrent.com/trials/abemaciclib-for-molecular-residual-disease-detected-by-circulating-tumor-dna-in-hr-her2-early-breast-cancer-28339https://curecurrent.com/trials/psychological-state-immunotherapy-response-and-multi-omics-signatures-in-tnbc-28340https://curecurrent.com/trials/a-prospective-cohort-study-of-handx-assisted-endoscopic-mastectomy-feasibility-and-safety-athena-i-study-28341https://curecurrent.com/trials/a-study-of-circulating-tumor-dna-ctdna-testing-for-people-with-b-cell-lymphoma-28342https://curecurrent.com/trials/evaluation-of-atra-activity-in-combination-with-anastrozole-in-pre-operative-phase-of-operable-early-breast-cancer-28343https://curecurrent.com/trials/fmt-in-triple-negative-breast-cancer-guided-by-ctdna-28344https://curecurrent.com/trials/standard-chemotherapy-plus-moxifloxacin-as-first-line-treatment-for-metastatic-triple-negative-breast-cancer-28345https://curecurrent.com/trials/moxifloxacin-in-adjuvant-treatment-of-patients-with-operable-breast-cancer-28346https://curecurrent.com/trials/a-randomised-controlled-trial-to-evaluate-the-impact-of-complement-theory-s-live-coactive-exercise-coaching-and-personal-28347https://curecurrent.com/trials/navigator-assisted-hypofractionation-navah-on-radiation-therapy-completion-in-breast-cancer-and-prostate-cancer-28348https://curecurrent.com/trials/better-biomarker-driven-early-therapeutic-selection-in-patients-with-hr-her2-metastatic-or-unresectable-breast-cancer-28349https://curecurrent.com/trials/digi-do-a-digital-information-tool-to-help-patients-diagnosed-with-breast-cancer-28350https://curecurrent.com/trials/decellularized-whole-donor-nipple-areola-complex-reconstruction-grafts-28351https://curecurrent.com/trials/definitive-radiation-therapy-for-inoperable-breast-cancer-28352https://curecurrent.com/trials/stereotactic-body-radiation-therapy-sbrt-for-invasive-breast-cancer-patients-not-undergoing-definitive-surgery-28353https://curecurrent.com/trials/cfdna-in-hereditary-and-high-risk-malignancies-2-28354https://curecurrent.com/trials/precision-physical-exercise-for-personalized-onco-hematology-28355https://curecurrent.com/trials/different-doses-of-dalpicicl-combined-with-letrozole-in-the-first-line-treatment-of-hr-positive-her2-negative-advanced-b-28356https://curecurrent.com/trials/psychoeducation-and-well-being-after-breast-cancer-28357https://curecurrent.com/trials/a-clinical-study-of-tj004309-with-atezolizumab-tecentriq-in-patients-with-ovarian-cancer-and-selected-solid-tumors-28358https://curecurrent.com/trials/phase-ii-trial-of-albumin-bound-paclitaxel-combined-with-nedaplatin-tp-via-hepatic-arterial-infusion-for-advanced-breast-28359https://curecurrent.com/trials/time-restricted-eating-and-cancer-clinical-outcomes-mechanisms-and-moderators-28360https://curecurrent.com/trials/the-true-face-of-the-pyramid-physical-activity-level-and-cardiovascular-risk-in-patients-with-breast-cancer-28361https://curecurrent.com/trials/a-study-to-assess-the-efficiency-of-trastuzumab-deruxtecan-in-russian-breast-cancer-patients-28362https://curecurrent.com/trials/temozolomide-monotherapy-or-in-combination-with-olaparib-in-patients-with-triple-negative-breast-cancer-tnbc-28363https://curecurrent.com/trials/combined-immunotherapies-in-metastatic-er-breast-cancer-28364https://curecurrent.com/trials/trial-of-neratinib-plus-capecitabine-in-subjects-with-her2-negative-metastatic-breast-cancer-with-brain-metastases-and-a-28365https://curecurrent.com/trials/trial-to-compare-radiation-fibrosis-with-five-versus-three-fractions-28366https://curecurrent.com/trials/wecanmanage-an-mhealth-self-management-tool-28367https://curecurrent.com/trials/auricular-acupuncture-and-hot-flashes-during-adjuvant-endocrine-therapy-28368https://curecurrent.com/trials/the-engaging-primary-care-in-cancer-survivorship-epics-study-28369https://curecurrent.com/trials/pharmacogenomic-and-circulating-biomarkers-for-cdk4-6-inhibitors-28370https://curecurrent.com/trials/targeted-intraoperative-radiotherapy-with-intrabeam-as-a-boost-for-breast-cancer-a-quality-control-registry-28371https://curecurrent.com/trials/the-development-of-masld-among-survivors-of-breast-or-colorectal-cancer-28372https://curecurrent.com/trials/abemaciclib-et-paclitaxel-in-aggressive-hr-her2-mbc-trial-28373https://curecurrent.com/trials/safety-and-efficacy-of-sgn-liv1a-plus-pembrolizumab-for-patients-with-locally-advanced-or-metastatic-triple-negative-bre-28374https://curecurrent.com/trials/evaluation-of-the-effect-of-alpha-lipoic-acid-on-radiation-induced-dermatitis-in-breast-cancer-patients-28375https://curecurrent.com/trials/adjuvant-treatment-for-high-risk-triple-negative-breast-cancer-patients-with-the-anti-pd-l1-antibody-avelumab-28376https://curecurrent.com/trials/preferences-of-patients-treated-with-oral-cancer-drugs-and-informal-caregivers-for-pharmaceutical-consultation-in-hospit-28377https://curecurrent.com/trials/clinical-trial-of-evaluating-tqb3912-tablets-combined-with-fulvestrant-injection-tqb3616-capsules-for-locally-advanced-o-28378https://curecurrent.com/trials/study-of-effects-of-dao-yin-exercise-on-the-patients-with-breast-cancer-post-operation-and-receiving-adjuvant-chemothera-28379https://curecurrent.com/trials/impact-of-cognitive-behavioural-therapy-for-insomnia-on-endocrine-therapy-adherence-28380https://curecurrent.com/trials/olaparib-in-the-treatment-of-brca1-2-unmutated-and-brca1-promoter-methylated-recurrent-and-metastatic-triple-negative-br-28381https://curecurrent.com/trials/a-study-of-gc203-til-in-advanced-malignant-solid-tumors-28382https://curecurrent.com/trials/a-study-of-mt-4561-in-patients-with-various-advanced-solid-tumors-28383https://curecurrent.com/trials/chemotherapy-combined-with-bevacizumab-neoadjuvant-therapy-for-her2-negative-breast-cancer-28384https://curecurrent.com/trials/dalpiciclib-plus-ai-neoadjuvant-endocrine-therapy-compared-with-neoadjuvant-chemotherapy-in-early-breast-cancer-ebc-28385https://curecurrent.com/trials/a-study-of-gc101-til-in-advanced-breast-cancer-10hospital-28386https://curecurrent.com/trials/adaptive-chemotherapy-for-the-treatment-of-advanced-breast-cancer-28387https://curecurrent.com/trials/food-for-thought-a-nutrition-intervention-for-women-undergoing-active-treatment-for-triple-negative-breast-cancer-28388https://curecurrent.com/trials/efficacy-and-safety-of-the-combination-of-trastuzumab-plus-tucatinib-plus-vinorelbine-in-patients-with-her2-positive-non-28389https://curecurrent.com/trials/survival-endpoints-in-women-treated-for-metastatic-breast-cancer-contribution-of-real-life-databases-28390https://curecurrent.com/trials/factors-influencing-tamoxifen-adherence-in-women-with-breast-cancer-receiving-tamoxifen-in-botswana-28391https://curecurrent.com/trials/pilot-study-to-evaluate-if-contrast-enhanced-ultrasound-ceus-can-predict-treatment-response-in-triple-negative-breast-ca-28392https://curecurrent.com/trials/rosuvastatin-for-prevention-of-anthracycline-induced-cardiac-dysfunction-in-breast-cancer-patients-28393https://curecurrent.com/trials/a-study-with-abbv-155-alone-and-in-combination-with-taxane-therapy-in-adults-with-relapsed-and-or-refractory-solid-tumor-28394https://curecurrent.com/trials/evaluation-of-efficiency-in-cancerology-of-new-technologies-as-telemedicine-and-conected-objects-e-domsant-28395https://curecurrent.com/trials/a-study-to-understand-the-treatment-patterns-and-patients-and-their-clinical-outcomes-who-are-taking-palbociclib-in-a-re-28396https://curecurrent.com/trials/health-education-for-women-with-breast-cancer-28397https://curecurrent.com/trials/adjuvant-ultra-hypofractionated-vs-hypofractionated-radiotherapy-for-early-breast-cancer-28398https://curecurrent.com/trials/a-multi-center-randomized-control-cross-over-study-to-evaluate-the-safety-and-effectiveness-of-the-dayspring-active-wear-28399https://curecurrent.com/trials/trend-02-a-phase-ii-exploratory-de-escalation-trial-of-neoadjuvant-sacituzumab-govitecan-plus-tislelizumab-sg-i-in-early-28400https://curecurrent.com/trials/serum-estradiol-levels-in-postmenopausal-women-with-breast-cancer-receiving-adjuvant-aromatase-inhibitors-and-vaginal-es-28401https://curecurrent.com/trials/mhealth-behavioral-cancer-pain-intervention-for-medically-underserved-patients-28402https://curecurrent.com/trials/the-effect-of-mobile-application-assisted-nursing-services-on-symptom-control-in-breast-cancer-patients-28403https://curecurrent.com/trials/study-to-evaluate-overall-survival-in-japanese-patients-with-hr-her2-advanced-breast-cancer-treated-with-palbociclib-plu-28404https://curecurrent.com/trials/yes-study-newly-diagnosed-metastatic-intervention-28405https://curecurrent.com/trials/5-vs-9-day-course-of-whole-breast-radiotherapy-with-boost-for-early-stage-breast-cancer-28406https://curecurrent.com/trials/effect-of-hand-message-on-catheter-insertion-28407https://curecurrent.com/trials/genetic-markers-of-susceptibility-to-chemotherapy-induced-ovarian-damage-in-cancer-patients-undergoing-ovarian-biopsy-fo-28408https://curecurrent.com/trials/a-phase-1b-2-study-of-t-dxd-combinations-in-her2-positive-metastatic-breast-cancer-28409https://curecurrent.com/trials/a-proof-of-concept-window-trial-of-the-immunological-effects-of-avelumab-and-aspirin-in-triple-negative-breast-cancer-28410https://curecurrent.com/trials/impact-of-osteopathic-manipulative-medicine-on-sentinal-lymph-node-biopsy-dye-and-tracer-uptake-28411https://curecurrent.com/trials/a-study-of-rucaparib-administered-with-radiation-in-patients-with-triple-negative-breast-cancer-with-an-incomplete-respo-28412https://curecurrent.com/trials/photon-craniospinal-irradiation-for-the-treatment-of-leptomeningeal-disease-secondary-to-breast-cancer-or-non-small-cell-28413https://curecurrent.com/trials/use-of-preoperative-postbiotic-supplementation-in-colorectal-cancer-surgery-28414https://curecurrent.com/trials/evaluation-of-a-mindfulness-intervention-to-prevent-chemo-brain-in-women-preparing-for-chemotherapy-for-breast-cancer-28415https://curecurrent.com/trials/rasolve-125i-radioactive-seed-marking-effects-on-pathological-complete-response-rate-and-prognosis-post-neoadjuvant-ther-28416https://curecurrent.com/trials/sacituzumab-govitecan-and-zimberelimab-w-srs-in-the-management-of-metastatic-triple-negative-breast-cancer-with-brain-me-28417https://curecurrent.com/trials/a-prospective-nis-to-evaluate-the-clinical-outcomes-of-risarg-ribociclib-combined-with-endocrine-therapy-or-chemotherapy-28418https://curecurrent.com/trials/clinical-study-to-evaluate-debio0123-sacituzumab-govitecan-combination-in-tnbc-or-hr-her2-advanced-breast-cancer-28419https://curecurrent.com/trials/specimen-pet-ct-imaging-for-intraoperative-margin-assessment-in-breast-cancer-28420https://curecurrent.com/trials/evaluation-of-the-added-value-of-logotherapy-in-the-psychological-support-of-patients-with-primary-breast-cancer-28421https://curecurrent.com/trials/minimal-residual-disease-in-solid-malignancies-28422https://curecurrent.com/trials/nab-p-cb-pd1-inhibitors-as-neoadjuvant-therapy-for-early-tnbc-28423https://curecurrent.com/trials/intraoperative-acupoint-stimulation-to-prevent-post-operative-nausea-and-vomiting-ponv-28424https://curecurrent.com/trials/phytocannabinoids-for-reducing-chronic-chemotherapy-induced-peripheral-neuropathy-in-breast-and-colon-cancer-survivors-28425https://curecurrent.com/trials/geriatric-assessment-and-promotores-gap-pilot-feasibility-study-28426https://curecurrent.com/trials/long-term-follow-up-in-patients-with-stage-0-iiic-breast-cancer-28427https://curecurrent.com/trials/a-nis-of-alpelisib-in-combination-with-fulvestrant-in-postmenopausal-women-and-men-with-hr-her2-locally-advanced-or-meta-28428https://curecurrent.com/trials/cdh1-germline-mutations-in-lobular-breast-cancer-28429https://curecurrent.com/trials/evaluation-of-a-plasma-protein-profile-as-a-predictive-biomarker-for-metastatic-relapse-in-triple-negative-breast-cancer-28430https://curecurrent.com/trials/preventive-strategy-for-immu132-related-aes-in-tnbc-or-luminal-breast-cancer-primed-28431https://curecurrent.com/trials/tucatinib-in-patients-with-locally-advanced-or-metastatic-her2-positive-breast-cancer-who-received-at-least-two-prior-an-28432https://curecurrent.com/trials/study-of-chemotherapy-induced-hair-changes-and-alopecia-skin-aging-and-nail-changes-in-women-with-non-metastatic-breast-28433https://curecurrent.com/trials/single-fraction-apbi-for-early-stage-breast-cancer-with-favorable-histological-subtypes-breast-1f-28434https://curecurrent.com/trials/lobularcard-trial-searching-for-novel-germline-mutations-in-lobular-breast-cancer-patients-28435https://curecurrent.com/trials/a-trial-of-15-fraction-vs-25-fraction-pencil-beam-scanning-proton-radiotherapy-after-mastectomy-in-patients-requiring-re-28436https://curecurrent.com/trials/multicentre-study-to-determine-the-feasibility-of-using-an-integrated-consent-model-to-compare-three-standard-of-care-re-28437https://curecurrent.com/trials/stereotactic-radiation-and-nivolumab-in-the-management-of-metastatic-breast-cancer-brain-metastases-28438https://curecurrent.com/trials/efficacy-and-safety-of-intrathecal-administration-of-thiotepa-in-combination-with-trastuzumab-in-breast-cancer-with-lept-28439https://curecurrent.com/trials/sequential-therapies-modeled-on-evolutionary-dynamics-for-breast-cancer-28440https://curecurrent.com/trials/vsv-02-compassionate-use-in-advanced-solid-tumors-28441https://curecurrent.com/trials/reverse-triple-negative-immune-resistant-breast-cancer-28442https://curecurrent.com/trials/organoids-from-breast-cancer-patients-treated-with-neoadjuvant-therapy-28443https://curecurrent.com/trials/pre-operative-irx-2-in-early-stage-breast-cancer-esbc-28444https://curecurrent.com/trials/prospective-breast-cancer-biospecimen-collection-28445https://curecurrent.com/trials/the-optimal-radioimmunotherapy-combinations-for-advanced-tnbc-28446https://curecurrent.com/trials/a-study-of-oleogel-s10-gel-for-the-treatment-of-radiation-dermatitis-in-people-with-breast-cancer-28447https://curecurrent.com/trials/improving-quality-of-life-for-patients-with-breast-cancer-invading-the-chest-wall-a-prospective-registry-for-patients-un-28448https://curecurrent.com/trials/breast-cancer-screening-in-ghana-28449https://curecurrent.com/trials/herombopag-treated-t-dm1-induced-platelet-reduction-28450https://curecurrent.com/trials/time-restricted-eating-in-survivors-trial-2-0-28451https://curecurrent.com/trials/optimal-methods-to-characterize-adc-resistance-in-solid-tumors-and-identify-clinically-useful-biomarkers-28452https://curecurrent.com/trials/diagnostic-performance-of-18f-fes-pet-ct-for-axillary-ln-metastasis-in-er-positive-breast-cancer-28453https://curecurrent.com/trials/evaluating-the-safety-tolerability-and-preliminary-anti-tumor-activity-of-mb0151-in-adult-subjects-with-advanced-solid-t-28454https://curecurrent.com/trials/a-nationwide-multicenter-single-arm-retrospective-study-of-delayed-endoscopic-dti-br-after-simple-mastectomy-28455https://curecurrent.com/trials/t-cell-receptor-gene-therapy-targeting-kk-lc-1-for-gastric-breast-cervical-lung-and-other-kk-lc-1-positive-epithelial-ca-28456https://curecurrent.com/trials/study-assessing-the-efficacy-and-safety-of-cannabidiol-oral-solution-for-joint-pain-of-adjuvant-endocrine-therapy-in-pat-28457https://curecurrent.com/trials/efficacy-and-safety-of-tenalisib-in-patients-with-metastatic-triple-negative-breast-cancer-tnbc-28458https://curecurrent.com/trials/a-clinical-study-to-explore-the-safety-tolerability-and-efficacy-of-recombinant-human-nsil12-oncolytic-adenovirus-inject-28459https://curecurrent.com/trials/personalised-disease-monitoring-in-metastatic-breast-cancer-28460https://curecurrent.com/trials/immune-cell-therapy-for-advanced-solid-tumors-28461https://curecurrent.com/trials/alternative-physical-activity-strategies-for-breast-cancer-survivors-28462https://curecurrent.com/trials/toripalimab-combined-with-anthracycline-free-or-anthracycline-containing-chemotherapy-as-neoadjuvant-chemotherapy-for-ea-28463https://curecurrent.com/trials/gentle-touch-for-post-mastectomy-lymphedema-28464https://curecurrent.com/trials/wrist-cooling-for-hot-flashes-clinical-trial-28465https://curecurrent.com/trials/kinetics-of-perioperative-circulating-dna-in-cancer-surgery-28466https://curecurrent.com/trials/evaluating-the-addition-of-elacestrant-oral-serd-to-olaparib-parp-inhibitor-in-patients-with-advanced-metastatic-hr-her2-28467https://curecurrent.com/trials/a-study-to-determine-the-efficacy-of-a-digital-self-management-support-tool-to-improve-the-quality-of-life-during-adjuva-28468https://curecurrent.com/trials/impact-of-neoadjuvant-immunotherapy-in-early-stage-breast-cancer-before-standard-therapy-28469https://curecurrent.com/trials/a-short-term-preoperative-evaluating-activity-and-safety-of-elacestrant-monotherapy-as-compared-to-elacestrant-ovarian-f-28470https://curecurrent.com/trials/bone-marrow-protection-safety-efficacy-of-trilaciclib-and-eribulin-in-locally-advanced-or-metastatic-tnbc-triple-negativ-28471https://curecurrent.com/trials/vitamin-k-d-chiro-inositol-and-lactalbumin-in-bone-homeostasis-28472https://curecurrent.com/trials/evaluation-of-neoadjuvant-therapy-with-trastuzumab-pertuzumab-docetaxel-and-ql1706-in-early-or-locally-advanced-her2-bre-28473https://curecurrent.com/trials/trastuzumab-plus-taxane-neoadjuvant-therapy-for-her2-positive-breast-ductal-carcinoma-in-situ-dcis-a-phase-ii-study-28474https://curecurrent.com/trials/a-new-tool-to-promote-patient-s-engagement-in-their-healthcare-process-28475https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-cypep-1-in-combination-with-pembrolizumab-for-the-treatment-of-advanced-o-28476https://curecurrent.com/trials/triple-negative-breast-cancer-markers-in-liquid-biopsies-using-artificial-intelligence-28477https://curecurrent.com/trials/a-study-on-nausea-and-vomiting-caused-by-t-dxd-in-breast-cancer-patients-28478https://curecurrent.com/trials/naptumomab-estafenatox-in-combination-with-durvalumab-in-subjects-with-selected-advanced-or-metastatic-solid-tumor-inclu-28479https://curecurrent.com/trials/vela-study-of-blu-222-in-advanced-solid-tumors-28480https://curecurrent.com/trials/integrating-clinical-protein-expression-and-genetic-markers-to-predict-lymphedema-in-breast-cancer-28481https://curecurrent.com/trials/effect-of-neoadjuvant-or-adjuvant-systemic-therapy-on-breast-cancers-bone-marrow-cancer-cells-and-circulating-cancer-cel-28482https://curecurrent.com/trials/combined-chemo-immunotherapy-plus-sbrt-in-neoadjuvant-treatment-for-luminal-subtype-breast-cancer-28483https://curecurrent.com/trials/tumor-integrating-gut-microbiota-in-breast-cancer-28484https://curecurrent.com/trials/study-in-patients-with-breast-cancer-leptomeningeal-metastasis-28485https://curecurrent.com/trials/a-study-of-pertuzumab-in-addition-to-chemotherapy-and-trastuzumab-as-adjuvant-therapy-in-participants-with-human-epiderm-28486https://curecurrent.com/trials/a-real-world-study-in-patients-with-hr-her2-advanced-breast-cancer-28487https://curecurrent.com/trials/evaluation-of-trop-2-adc-in-breast-cancer-patients-with-brain-metastases-a-real-world-study-28488https://curecurrent.com/trials/pilot-clinical-evaluation-of-a-microwave-imaging-system-for-breast-cancer-detection-28489https://curecurrent.com/trials/a-study-of-cea-targeted-car-t-therapy-in-patients-with-cea-positive-advanced-solid-tumors-28490https://curecurrent.com/trials/triple-b-study-carboplatin-cyclophosphamide-versus-paclitaxel-with-or-without-atezolizumab-as-first-line-treatment-in-ad-28491https://curecurrent.com/trials/study-comparing-ec-t-verses-pcb-in-the-adjuvant-chemotherapy-of-non-triple-negative-breast-cancer-28492https://curecurrent.com/trials/a-trial-comparing-screening-mammography-with-and-without-assistance-from-artificial-intelligence-for-breast-cancer-detec-28493https://curecurrent.com/trials/a-study-of-yl202-in-selected-patients-with-advanced-solid-tumors-28494https://curecurrent.com/trials/motiva-flora-aesthetic-breast-recon-clinical-study-28495https://curecurrent.com/trials/impact-of-pegfilgrastim-on-trastuzumab-anti-tumor-effect-and-adcc-in-operable-her2-breast-cancer-breast-cancer-28496https://curecurrent.com/trials/standard-treatment-sbrt-in-solid-tumors-patients-with-between-1-and-5-bone-only-metastases-28497https://curecurrent.com/trials/basket-study-for-oligo-metastatic-breast-cancer-28498https://curecurrent.com/trials/molecular-and-cellular-analysis-of-breast-cancer-28499https://curecurrent.com/trials/the-impact-of-intraoperative-methadone-on-postoperative-opioid-use-28500https://curecurrent.com/trials/chemosensitivity-during-phases-of-the-menstrual-cycle-in-breast-cancer-patients-28501https://curecurrent.com/trials/fulvestrant-akt-inhibition-in-advanced-aromatase-inhibitor-resistant-breast-cancer-28502https://curecurrent.com/trials/save-trial-safe-opioid-use-video-education-28503https://curecurrent.com/trials/a-real-life-study-to-understand-the-use-and-effects-of-palbociclib-in-us-patients-with-breast-cancer-28504https://curecurrent.com/trials/the-effect-of-myofascial-release-exercises-on-viscoelastic-changes-of-the-pectoralis-major-muscle-pain-range-of-motion-a-28505https://curecurrent.com/trials/trial-of-hypofractionated-radiotherapy-in-combination-with-medi4736-and-tremelimumab-for-patients-with-metastatic-melano-28506https://curecurrent.com/trials/study-evaluating-peg-g-csf-injectionin-preventing-neutropenia-after-chemotherapy-28507https://curecurrent.com/trials/intrathecal-chemotherapy-through-ommaya-reservoir-upon-her-2-negative-breast-cancer-with-leptomeningeal-metastasis-28508https://curecurrent.com/trials/chronic-cancer-pain-management-program-28509https://curecurrent.com/trials/confocal-histolog-scanner-in-routine-breast-conserving-surgery-chib-28510https://curecurrent.com/trials/quilt-3-038-active-immunotherapy-cea-vaccine-in-patients-with-malignancies-expressing-cea-28511https://curecurrent.com/trials/breast-choice-decision-tool-r21-aim2-28512https://curecurrent.com/trials/ipp-psp-block-vs-spsipb-in-breast-surgery-28513https://curecurrent.com/trials/olaparib-radiation-therapy-for-patients-triple-negative-breast-cancer-tnbc-28514https://curecurrent.com/trials/neutrophil-biomarker-test-for-predicting-clinical-benefit-from-immunotherapy-based-on-flow-cytometry-analysis-28515https://curecurrent.com/trials/use-of-dapagliflozin-in-primary-prevention-of-cardiotoxicity-of-anthracycline-chemotherapy-in-breast-cancer-patients-28516https://curecurrent.com/trials/breast-cancer-risk-after-diagnostic-gene-sequencing-28517https://curecurrent.com/trials/the-preoperative-health-body-study-28518https://curecurrent.com/trials/shaving-as-an-safe-alternative-to-frozen-section-analysis-28519https://curecurrent.com/trials/community-clinic-model-to-improve-early-detection-of-breast-and-cervical-cancers-in-kenya-28520https://curecurrent.com/trials/validity-of-her2-amplified-circulating-tumor-cells-to-select-metastatic-breast-cancer-considered-her2-negative-for-trast-28521https://curecurrent.com/trials/sac-tmt-combined-with-toripalimab-for-first-line-treatment-of-pd-l1-positive-a-mtnbc-28522https://curecurrent.com/trials/assessment-of-response-to-neo-adjuvant-chemotherapy-for-patients-with-a-locally-advanced-breast-cancer-with-3d-elastogra-28523https://curecurrent.com/trials/phase-1-2-study-of-amcenestrant-sar439859-single-agent-and-in-combination-with-other-anti-cancer-therapies-in-postmenopa-28524https://curecurrent.com/trials/post-marketing-surveillance-study-to-observe-safety-and-efficacy-of-ibrance-28525https://curecurrent.com/trials/comparative-sensory-mapping-of-regional-anesthesia-techniques-in-breast-cancer-surgery-28526https://curecurrent.com/trials/intrathecal-trastuzumab-administration-in-metastatic-breast-cancer-patients-developing-carcinomatous-meningitis-28527https://curecurrent.com/trials/a-post-treatment-supportive-service-program-for-the-transition-into-survivorship-for-black-women-breast-cancer-survivors-28528https://curecurrent.com/trials/moderate-intensity-exercise-and-pain-sensitization-in-breast-cancer-survivors-a-case-based-study-28529https://curecurrent.com/trials/brain-18f-fes-pet-ct-in-patients-with-estrogen-receptor-positive-breast-cancer-28530https://curecurrent.com/trials/avoiding-surgery-in-estrogen-receptor-positive-atypical-ductal-hyperplasia-and-in-situ-carcinoma-treated-with-endocrine-28531https://curecurrent.com/trials/circulating-tumor-cells-to-guide-chemotherapy-for-metastatic-breast-cancer-28532https://curecurrent.com/trials/physical-activity-proliferation-and-immune-markers-in-benign-breast-tissue-28533https://curecurrent.com/trials/a-study-of-ql1706-combined-with-short-cycle-anthracyclines-or-taxanes-for-the-treatment-of-early-stage-tnbc-28534https://curecurrent.com/trials/a-phase-1-study-of-oral-op-1250-in-combination-with-palbociclib-in-hr-her2-breast-cancer-patients-28535https://curecurrent.com/trials/washu-diep-flap-video-and-patient-understanding-improvement-28536https://curecurrent.com/trials/a-phase-ii-multicenter-open-label-study-to-evaluate-the-efficacy-and-safety-of-neoadjuvant-therapy-with-inavolisib-plus-28537https://curecurrent.com/trials/resistance-and-aerobic-exercise-for-prevention-in-women-with-dense-breasts-rep-d-28538https://curecurrent.com/trials/developing-screening-clinical-breast-examination-implementation-strategies-in-south-africa-28539https://curecurrent.com/trials/mbc-physical-activity-study-28540https://curecurrent.com/trials/enhancing-mammography-programs-for-outreach-wellness-education-and-resources-empower-in-underserved-populations-study-28541https://curecurrent.com/trials/treatment-of-breast-cancer-with-trastuzumab-hs627-pertuzumab-docetaxel-28542https://curecurrent.com/trials/exercise-prehabilitation-of-breast-cancer-28543https://curecurrent.com/trials/a-study-to-reduce-persistent-post-mastectomy-pain-using-opioid-free-anesthesia-28544https://curecurrent.com/trials/ashby-accelerated-super-hypofractionated-breast-brachytherapy-28545https://curecurrent.com/trials/hetrombopag-for-the-prevention-of-adc-induced-thrombocytopenia-in-breast-cancer-an-exploratory-dual-cohort-phase-2-study-28546https://curecurrent.com/trials/a-clinical-trial-assessing-bt-001-alone-and-in-combination-with-pembrolizumab-in-metastatic-or-advanced-solid-tumors-28547https://curecurrent.com/trials/her2-pet-as-a-precision-imaging-tool-for-treatment-with-her2-adc-in-her2-expressing-mbc-28548https://curecurrent.com/trials/trial-of-bdc-1001-pertuzumab-in-subjects-with-her2-positive-metastatic-breast-cancer-28549https://curecurrent.com/trials/drain-removal-on-postoperative-safety-and-patient-satisfaction-in-r-e-nsm-with-prepectoral-dibr-28550https://curecurrent.com/trials/evaluation-of-individual-sensitivity-to-the-gonadotoxicity-of-chemotherapy-in-young-patients-with-breast-cancer-28551https://curecurrent.com/trials/sustainable-and-efficient-platform-trial-of-new-therapeutic-development-for-early-breast-cancer-28552https://curecurrent.com/trials/a-study-of-ado-trastuzumab-emtansine-t-dm1-induced-peripheral-neuropathy-in-her2-positive-breast-cancer-patients-28553https://curecurrent.com/trials/a-multicenter-phase-iii-clinical-study-and-translational-research-on-adaptive-neoadjuvant-therapy-of-de-escalation-and-e-28554https://curecurrent.com/trials/evaluation-of-an-automated-system-to-culture-metastatic-patient-circulating-tumor-cells-in-embryonated-chicken-eggs-in-o-28555https://curecurrent.com/trials/estradiol-plus-olaparib-for-breast-cancer-phoebe-28556https://curecurrent.com/trials/eribulin-with-or-without-trastuzumab-biosimilar-in-patients-with-her2-overexpressed-recurrent-or-stage-iv-breast-cancer-28557https://curecurrent.com/trials/a-study-of-entinostat-in-combination-with-fulvestrant-for-the-treatment-of-locally-advanced-or-metastatic-breast-cancer-28558https://curecurrent.com/trials/living-conditions-and-breast-cancer-28559https://curecurrent.com/trials/attenuating-cancer-treatment-related-toxicity-in-oncology-patients-with-a-tailored-physical-exercise-program-28560https://curecurrent.com/trials/evaluation-of-the-cardioprotective-effect-of-nebivolol-on-trastuzumab-induced-cardiotoxicity-in-breast-cancer-patients-28561https://curecurrent.com/trials/adjuvant-therapy-with-abemaciclib-soc-et-vs-soc-et-in-clinical-or-genomic-high-risk-hr-her2-ebc-28562https://curecurrent.com/trials/adjuvant-cdk4-6-inhibitor-use-in-hr-her2-breast-cancer-28563https://curecurrent.com/trials/evaluation-of-well-being-and-patient-reported-outcomes-after-robotic-single-port-nipple-sparing-mastectomy-and-implant-r-28564https://curecurrent.com/trials/using-cics-1-and-spm-011-and-18f-fbpa-commissioned-by-cics-and-sumitomo-heavy-industries-and-stella-pharma-28565https://curecurrent.com/trials/locoregional-blocks-for-breast-cancer-surgeries-28566https://curecurrent.com/trials/living-well-program-impact-on-healthcare-costs-and-clinical-outcomes-in-breast-cancer-care-28567https://curecurrent.com/trials/elvn-002-with-trastuzumab-chemotherapy-in-her2-solid-tumors-colorectal-and-breast-cancer-28568https://curecurrent.com/trials/ds8201a-and-pembrolizumab-in-participants-with-locally-advanced-metastatic-breast-or-non-small-cell-lung-cancer-28569https://curecurrent.com/trials/capecitabine-tucatinib-and-intrathecal-trastuzumab-for-breast-cancer-patients-with-leptomeningeal-disease-28570https://curecurrent.com/trials/continuous-or-intermittent-pyrotinib-for-her2-positive-advanced-breast-cancer-28571https://curecurrent.com/trials/study-of-sexual-quality-of-life-in-women-with-breast-cancer-who-had-multidisciplinary-management-with-photobiomodulation-28572https://curecurrent.com/trials/a-study-of-mhb036c-combined-with-mhb039a-in-patients-with-advanced-breast-cancer-or-other-advanced-malignant-solid-tumor-28573https://curecurrent.com/trials/early-detection-of-cardiotoxicity-from-systemic-and-radiation-therapy-in-breast-cancer-patients-28574https://curecurrent.com/trials/trastuzumab-deruxtecan-in-advanced-breast-cancer-28575https://curecurrent.com/trials/margetuximab-or-trastuzumab-margot-28576https://curecurrent.com/trials/comparing-the-qor-of-pecs-block-and-ga-in-breast-conserving-surgery-with-sentinel-lymph-node-biopsy-28577https://curecurrent.com/trials/targeted-palliative-care-intervention-for-patients-with-metastatic-breast-cancer-28578https://curecurrent.com/trials/adjusting-the-dose-of-therapeutic-exercise-to-prevent-neurotoxicity-due-to-anticancer-treatment-atento-28579https://curecurrent.com/trials/evaluation-of-sleep-quality-in-prostate-cancer-patients-undergoing-treatment-with-hormonal-therapeutic-approaches-and-in-28580https://curecurrent.com/trials/cervical-motor-control-in-long-term-breast-cancer-survivors-28581https://curecurrent.com/trials/iparomlimab-and-tuvonralimab-ql1706-in-patients-with-hr-positive-her2-negative-advanced-breast-cancer-28582https://curecurrent.com/trials/palbociclib-and-circulating-tumor-dna-for-esr1-mutation-detection-28583https://curecurrent.com/trials/continuous-or-intermittent-extension-of-adjuvant-pyrotinib-for-invasive-her2-positive-breast-cancer-28584https://curecurrent.com/trials/preventing-chemotherapy-induced-peripheral-neuropathy-using-presiona-exercise-program-28585https://curecurrent.com/trials/lymphovenous-bypass-procedure-for-secondary-prevention-of-lymphedema-in-breast-cancer-28586https://curecurrent.com/trials/low-dose-exemestane-vs-low-dose-tamoxifen-in-post-menopausal-women-at-high-risk-for-breast-cancer-28587https://curecurrent.com/trials/are-ck-cd45-double-positive-circulating-cells-of-tumor-origin-characterization-in-metastatic-breast-cancer-28588https://curecurrent.com/trials/study-to-compare-overall-survival-in-medicare-patients-with-metastatic-breast-cancer-treated-with-a-medicine-called-palb-28589https://curecurrent.com/trials/study-bt5528-100-in-patients-with-advanced-solid-tumors-associated-with-epha2-expression-28590https://curecurrent.com/trials/a-study-to-learn-about-the-safety-of-talzenna-for-the-treatment-of-breast-cancer-28591https://curecurrent.com/trials/capecitabine-plus-pembrolizumab-in-patients-with-triple-negative-breast-cancer-after-chemo-immunotherapy-and-surgery-28592https://curecurrent.com/trials/effect-of-espb-on-postoperative-pain-in-patients-with-breast-cancer-implant-reconstruction-28593https://curecurrent.com/trials/robotic-surgery-via-bilateral-axillo-breast-approach-for-relatively-low-risk-papillary-thyroid-carcinoma-with-lateral-ce-28594https://curecurrent.com/trials/reverse-her2-negative-immune-resistant-breast-cancer-28595https://curecurrent.com/trials/a-study-to-learn-more-about-tukysa-once-it-is-out-in-the-korean-market-28596https://curecurrent.com/trials/building-on-trust-navigating-preventive-lung-breast-and-prostate-cancer-screenings-at-community-resource-spots-28597https://curecurrent.com/trials/robot-assisted-vs-open-nipple-sparing-mastectomy-with-immediate-breast-reconstruction-28598https://curecurrent.com/trials/stress-management-intervention-among-breast-and-gynecologic-cancer-patients-in-viet-nam-28599https://curecurrent.com/trials/prediction-of-long-term-arm-morbidity-following-breast-cancer-surgeries-and-treatments-28600https://curecurrent.com/trials/treatment-with-tucatinib-in-patients-with-an-isolated-brain-progression-of-a-metastatic-breast-cancer-28601https://curecurrent.com/trials/study-of-bdc-3042-as-single-agent-and-in-combination-with-cemiplimab-in-patients-with-advanced-malignancies-28602https://curecurrent.com/trials/impact-of-a-patient-decision-aid-intervention-28603https://curecurrent.com/trials/positron-emission-tomography-in-women-with-advanced-her2-positive-breast-cancer-28604https://curecurrent.com/trials/pilot-trial-of-preop-partial-radiation-in-breast-cancer-patients-28605https://curecurrent.com/trials/octane-adjuvant-liposomal-doxorubicin-and-carboplatin-for-early-stage-triple-negative-breast-cancer-28606https://curecurrent.com/trials/cu64-dota-trastuzumab-pet-and-markers-predicting-response-to-neoadjuvant-trastuzumab-pertuzum-in-her2-breast-cancer-28607https://curecurrent.com/trials/radiant-pre-op-radiation-with-abemaciclib-and-letrozole-28608https://curecurrent.com/trials/a-study-of-pf-06873600-in-people-with-cancer-28609https://curecurrent.com/trials/platform-trial-assessing-uptake-safety-and-efficacy-of-theranostic-agents-in-solid-tumors-with-active-brain-metastases-28610https://curecurrent.com/trials/study-bt8009-100-in-subjects-with-nectin-4-expressing-advanced-malignancies-28611https://curecurrent.com/trials/statins-for-reduction-of-cardiac-toxicity-in-patients-receiving-her2-targeted-28612https://curecurrent.com/trials/a-study-of-faz053-single-agent-and-in-combination-with-pdr001-in-patients-with-advanced-malignancies-28613https://curecurrent.com/trials/a-study-of-tas-120-in-patients-with-metastatic-breast-cancer-28614https://curecurrent.com/trials/biomarkers-and-clinical-features-of-metastatic-breast-cancer-in-patients-treated-with-cdk4-6-inhibitors-28615https://curecurrent.com/trials/dpyd-pharmacogenomics-and-fluoropyrimidine-fp-dose-adjustment-28616https://curecurrent.com/trials/breast-re-irradiation-after-second-ipsilateral-lumpectomy-28617https://curecurrent.com/trials/ultrahypofractionation-and-normal-tissue-toxicity-28618https://curecurrent.com/trials/neuromodulation-of-central-sensory-integration-to-improve-postural-control-28619https://curecurrent.com/trials/abemaciclib-in-treating-patients-with-surgically-resectable-chemotherapy-resistant-triple-negative-breast-cancer-28620https://curecurrent.com/trials/a-study-of-ly3484356-in-women-with-breast-cancer-before-having-surgery-28621https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-atezolizumab-plus-chemotherapy-for-patients-with-early-relapsing-recurrent-triple-28622https://curecurrent.com/trials/utilizing-advocates-and-supporters-to-increase-lung-cancer-screening-rates-in-eligible-participants-28623https://curecurrent.com/trials/mobile-apps-to-reduce-distress-in-breast-cancer-survivors-using-an-adaptive-design-28624https://curecurrent.com/trials/trastuzumab-deruxtecan-alone-or-in-combination-with-anastrozole-for-the-treatment-of-early-stage-her2-low-hormone-recept-28625https://curecurrent.com/trials/a-study-of-a-comprehensive-prevention-program-to-reduce-lymphedema-after-axillary-lymph-node-dissection-in-people-with-b-28626https://curecurrent.com/trials/neratinib-in-combination-with-ruxolitinib-in-patients-with-mtnbc-28627https://curecurrent.com/trials/a-study-of-multiple-immunotherapy-based-treatment-combinations-in-hormone-receptor-hr-positive-human-epidermal-growth-fa-28628https://curecurrent.com/trials/promoting-resilience-in-women-with-breast-cancer-28629https://curecurrent.com/trials/tmem-mri-a-pilot-feasibility-study-of-mri-for-imaging-of-tmem-in-patients-with-operable-breast-cancer-28630https://curecurrent.com/trials/excision-followed-by-radiofrequency-ablation-for-breast-cancer-28631https://curecurrent.com/trials/a-study-of-zilovertamab-vedotin-mk-2140-vls-101-in-participants-with-solid-tumors-mk-2140-002-28632https://curecurrent.com/trials/culturally-informed-counseling-in-latinas-at-high-risk-for-hereditary-breast-or-ovarian-cancer-28633https://curecurrent.com/trials/axillary-reverse-mapping-28634https://curecurrent.com/trials/women-s-moonshot-neoadjuvant-treatment-with-pact-for-patients-with-locally-advanced-tnbc-28635https://curecurrent.com/trials/mirai-mri-validation-of-ai-models-for-breast-cancer-risk-28636https://curecurrent.com/trials/targeted-intra-operative-radiotherapy-for-the-management-of-ductal-carcinoma-in-situ-of-the-breast-28637https://curecurrent.com/trials/mechanisms-predictors-and-social-determinants-of-cardiotoxicity-in-breast-cancer-28638https://curecurrent.com/trials/nuv-868-as-monotherapy-and-in-combination-with-olaparib-or-enzalutamide-in-adult-patients-with-advanced-solid-tumors-28639https://curecurrent.com/trials/pragmatic-randomized-trial-of-proton-vs-photon-therapy-for-patients-with-non-metastatic-breast-cancer-a-radiotherapy-com-28640https://curecurrent.com/trials/study-of-boserolimab-mk-5890-as-monotherapy-and-in-combination-with-pembrolizumab-mk-3475-in-adults-with-advanced-solid-28641https://curecurrent.com/trials/navah-impact-on-radiation-therapy-completion-in-black-breast-prostate-cancer-patients-28642https://curecurrent.com/trials/enhancing-access-to-supportive-services-for-women-of-color-with-metastatic-breast-cancer-28643https://curecurrent.com/trials/daance-for-chemotherapy-induced-neuropathy-28644https://curecurrent.com/trials/shorter-chemo-immunotherapy-without-anthracycline-drugs-for-early-stage-triple-negative-breast-cancer-28645https://curecurrent.com/trials/study-of-magrolimab-combination-therapy-in-patients-with-non-surgically-removable-locally-advanced-or-metastatic-triple-28646https://curecurrent.com/trials/a-study-of-flibanserin-in-breast-cancer-survivors-on-tamoxifen-or-aromatase-inhibitors-28647https://curecurrent.com/trials/genomic-structural-variation-in-cancer-susceptibility-28648https://curecurrent.com/trials/a-phase-i-ii-study-of-vls-1488-in-subjects-with-advanced-cancer-28649https://curecurrent.com/trials/post-mastectomy-recovery-comparing-preoperative-pecs-ii-blocks-with-intraoperative-pectoral-blocks-28650https://curecurrent.com/trials/rad-1802-pilot-trial-of-five-fraction-stereotactic-body-radiotherapy-for-early-stage-breast-cancer-patients-eligible-for-28651https://curecurrent.com/trials/clinical-trial-of-avasopasem-in-patients-with-metastatic-hormone-receptor-positive-breast-cancer-with-progression-on-a-c-28652https://curecurrent.com/trials/treatment-landscape-and-real-world-dosing-patterns-with-cdk4-6-inhibitors-for-breast-cancer-in-portugal-28653https://curecurrent.com/trials/lifting-more-than-weights-resistance-exercise-program-across-socioeconomic-groups-for-cancer-related-fatigue-management-28654https://curecurrent.com/trials/breast-cancer-survivors-who-experience-aromatase-inhibitor-associated-musculoskeletal-symptoms-aimss-28655https://curecurrent.com/trials/crizotinib-in-lobular-breast-diffuse-gastric-and-triple-negative-lobular-breast-cancer-or-cdh1-mutated-solid-tumours-28656https://curecurrent.com/trials/neoadjuvant-darolutamide-alone-or-in-combination-with-standard-therapy-for-stage-ii-iiia-ar-tnbc-28657https://curecurrent.com/trials/phase-1-2-study-of-intratumoral-injection-of-stx-001-in-advanced-solid-tumors-as-monotherapy-or-in-combination-with-pemb-28658https://curecurrent.com/trials/high-risk-breast-clinic-protocol-for-women-at-increased-risk-for-developing-breast-cancer-28659https://curecurrent.com/trials/phase-iib-trial-of-bazedoxifene-plus-conjugated-estrogens-28660https://curecurrent.com/trials/ultra-hypofractionated-whole-breast-irradiation-with-lumpectomy-cavity-boost-for-the-treatment-of-stage-i-iii-breast-can-28661https://curecurrent.com/trials/pilot-study-of-bazedoxifene-plus-conjugated-estrogen-on-imaging-and-blood-biomarkers-28662https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-chemotherapy-vs-placebo-plus-chemotherapy-as-neoadjuvant-therapy-and-pembrolizumab-v-28663https://curecurrent.com/trials/genetic-education-in-brca-families-28664https://curecurrent.com/trials/niraparib-in-the-treatment-of-patients-with-advanced-palb2-mutated-tumors-28665https://curecurrent.com/trials/synergy-ai-artificial-intelligence-based-precision-oncology-clinical-trial-matching-and-registry-28666https://curecurrent.com/trials/mobile-weight-loss-intervention-for-adolescent-and-young-adult-cancer-survivors-28667https://curecurrent.com/trials/supporting-women-with-breast-cancer-to-prepare-for-treatment-the-prepare-study-28668https://curecurrent.com/trials/preventing-dato-dxd-associated-stomatitis-with-dexamethasone-mouthwash-tropion-dm-28669https://curecurrent.com/trials/nbtxr3-activated-by-radiotherapy-for-patients-with-advanced-cancers-treated-with-an-anti-pd-1-therapy-28670https://curecurrent.com/trials/breast-mapping-and-detection-of-suspicious-breast-lesions-using-feminai-28671https://curecurrent.com/trials/physical-activity-promotion-for-breast-and-endometrial-cancer-survivors-28672https://curecurrent.com/trials/study-of-h3b-6545-in-japanese-women-with-estrogen-receptor-er-positive-human-epidermal-growth-factor-receptor-2-her2-neg-28673https://curecurrent.com/trials/study-to-evaluate-safety-and-dosimetry-of-18f-geh121224-in-patients-with-locally-advanced-or-metastatic-breast-cancer-28674https://curecurrent.com/trials/physical-activity-intervention-for-the-improvement-of-pain-in-young-hispanic-breast-cancer-survivors-28675https://curecurrent.com/trials/surviving-daily-life-28676https://curecurrent.com/trials/pre-operative-window-of-adjuvant-endocrine-therapy-to-inform-rt-decisions-in-older-women-with-early-stage-breast-cancer-28677https://curecurrent.com/trials/subclinical-lymphedema-treatment-study-28678https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-combined-with-fulvestrant-in-women-with-hormone-receptor-positive-her2-negative-breast-28679https://curecurrent.com/trials/open-label-safety-and-tolerability-study-of-incb057643-in-subjects-with-advanced-malignancies-28680https://curecurrent.com/trials/surgical-breast-resection-with-or-without-axillary-lymph-node-excision-in-treating-women-with-breast-cancer-28681https://curecurrent.com/trials/collecting-tissue-samples-for-future-research-from-women-undergoing-surgery-for-breast-cancer-28682https://curecurrent.com/trials/a-study-to-compare-db-1303-bnt323-versus-t-dm1-in-breast-cancer-28683https://curecurrent.com/trials/strength-after-breast-cancer-28684https://curecurrent.com/trials/a-study-of-hmbd-002-a-monoclonal-antibody-targeting-vista-as-monotherapy-and-combined-with-pembrolizumab-in-patients-wit-28685https://curecurrent.com/trials/study-of-the-monoclonal-antibody-imt-009-in-patients-with-advanced-solid-tumors-or-lymphomas-28686https://curecurrent.com/trials/study-of-2-ribociclib-doses-in-combination-with-aromatase-inhibitors-in-women-with-hr-her2-advanced-breast-cancer-28687https://curecurrent.com/trials/unc-pleural-fluid-registry-28688https://curecurrent.com/trials/complete-decongestive-therapy-versus-non-pneumatic-compression-therapy-in-post-mastectomy-lymphedema-28689https://curecurrent.com/trials/a-phase-1a-1b-study-of-actm-838-in-patients-with-advanced-solid-tumors-28690https://curecurrent.com/trials/benefit-of-a-diagnostic-mri-in-case-of-pathological-nipple-discharge-with-normal-mammography-ultrasound-28691https://curecurrent.com/trials/serum-biomarkers-to-characterize-the-effects-of-therapy-on-ovarian-reserve-in-premenopausal-women-with-early-stage-breas-28692https://curecurrent.com/trials/a-study-of-tas2940-in-participants-with-locally-advanced-or-metastatic-solid-tumor-cancer-28693https://curecurrent.com/trials/yasu-research-registry-for-young-adults-with-cancer-28694https://curecurrent.com/trials/what-women-want-real-time-results-during-screening-mammography-in-the-era-of-patient-experience-driven-care-28695https://curecurrent.com/trials/tablet-based-mobile-health-ultrasound-for-point-of-care-breast-cancer-diagnosis-in-nigeria-mobile-health-technology-and-28696https://curecurrent.com/trials/feasibility-of-chemotherapy-de-escalation-in-early-stage-her2-positive-breast-cancer-28697https://curecurrent.com/trials/advanced-ultrasound-signal-processing-of-suspicious-breast-images-28698https://curecurrent.com/trials/monitoring-neoadjuvant-chemotherapy-response-in-breast-cancer-patients-using-diffuse-optical-spectroscopic-imaging-28699https://curecurrent.com/trials/efficacy-and-safety-study-of-eg1206a-eirgenix-pertuzumab-compared-with-eu-sourced-perjeta-pertuzumab-in-patients-with-he-28700https://curecurrent.com/trials/molecular-analyses-to-predict-pathways-of-endocrine-resistance-following-short-term-neoadjuvant-endocrine-treatment-in-p-28701https://curecurrent.com/trials/study-of-68ga-ff58-in-patients-with-selected-solid-tumors-expected-to-overexpress-v-3-and-v-5-integrins-28702https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-trastuzumab-emtansine-t-dm1-as-therapy-in-chinese-participants-with-28703https://curecurrent.com/trials/evaluate-the-accuracy-of-breast-mri-biopsy-in-diagnosing-a-complete-tumor-response-for-some-women-following-neoadjuvant-28704https://curecurrent.com/trials/the-compassion-study-28705https://curecurrent.com/trials/pr-ceal-community-outreach-engagement-group-28706https://curecurrent.com/trials/the-cancer-of-the-pancreas-screening-5-caps5-study-28707https://curecurrent.com/trials/topical-afimoxifene-in-treating-patients-with-breast-cancer-who-have-undergone-radiation-therapy-on-one-breast-28708https://curecurrent.com/trials/risk-guided-cardioprotection-with-carvedilol-in-breast-cancer-patients-treated-with-doxorubicin-and-or-trastuzumab-28709https://curecurrent.com/trials/ucf-mammochat-image-repository-28710https://curecurrent.com/trials/evaluating-the-effects-of-genetic-testing-on-patients-stress-levels-28711https://curecurrent.com/trials/s1501-dual-observational-and-randomized-cohort-study-of-patients-with-metastatic-her-2-breast-cancer-at-risk-of-cardiac-28712https://curecurrent.com/trials/tka-assay-for-cdk4-6i-28713https://curecurrent.com/trials/cdk4-6-inhibitor-intensification-and-chemotherapy-de-escalation-for-early-stage-luminal-her2-breast-cancer-28714https://curecurrent.com/trials/calm-managing-distress-in-malignant-brain-cancer-28715https://curecurrent.com/trials/axillary-nodal-burden-in-her2-and-tnbc-28716https://curecurrent.com/trials/a-study-of-zen003694-and-talazoparib-in-patients-with-triple-negative-breast-cancer-28717https://curecurrent.com/trials/nonlinear-elasticity-mapping-of-breast-masses-28718https://curecurrent.com/trials/phase-1-2-clinical-trial-of-cp-506-hap-in-monotherapy-or-with-carboplatin-or-ici-28719https://curecurrent.com/trials/real-world-outcomes-of-patients-with-metastatic-breast-cancer-after-treatment-with-first-line-et-cdk4-6i-28720https://curecurrent.com/trials/sustainable-implementation-of-the-excel-exercise-oncology-program-across-canada-28721https://curecurrent.com/trials/healiaid-collagen-wound-dressing-in-patients-undergoing-breast-tumor-surgery-28722https://curecurrent.com/trials/a-multi-center-investigation-of-family-health-28723https://curecurrent.com/trials/cisplatin-plus-romidepsin-nivolumab-in-locally-recurrent-or-metastatic-triple-negative-breast-cancer-tnbc-28724https://curecurrent.com/trials/an-in-situ-detection-for-microrna-28725https://curecurrent.com/trials/onloop-trial-evaluating-a-new-surveillance-and-support-system-for-survivors-of-childhood-cancer-in-ontario-28726https://curecurrent.com/trials/a-retrospective-observational-study-of-patients-with-early-stage-her2-positive-breast-cancer-treated-with-neratinib-28727https://curecurrent.com/trials/3-d-super-resolution-ultrasound-microvascular-imaging-28728https://curecurrent.com/trials/local-compression-seroma-diminution-objective-clodis-28729https://curecurrent.com/trials/mri-in-evaluating-early-response-to-chemotherapy-in-women-with-infiltrating-breast-cancer-28730https://curecurrent.com/trials/distribution-of-the-homologous-recombination-related-hrr-genesmutationsand-hrd-in-breast-cancer-28731https://curecurrent.com/trials/pilot-study-of-a-mind-diet-intervention-in-women-undergoing-active-treatment-for-breast-cancer-28732https://curecurrent.com/trials/study-of-sacituzumab-govitecan-versus-treatment-of-physician-s-choice-in-patients-with-hormone-receptor-positive-human-e-28733https://curecurrent.com/trials/feasibility-trial-of-scarwork-for-post-breast-surgery-pain-syndrome-28734https://curecurrent.com/trials/impact-of-a-food-supplement-on-musculoskeletal-pain-in-women-with-breast-cancer-treated-with-aromatase-inhibitors-28735https://curecurrent.com/trials/community-led-navigation-to-address-disparities-in-mammography-among-native-american-women-28736https://curecurrent.com/trials/radioguided-occult-lesion-localisation-by-indocyanine-green-28737https://curecurrent.com/trials/testing-an-omega-3-fatty-acid-based-anti-cancer-therapy-for-patients-with-triple-negative-inflammatory-breast-cancer-tha-28738https://curecurrent.com/trials/ai-based-self-supervised-learning-model-using-non-contrast-breast-mri-for-early-screening-and-clinical-utility-evaluatio-28739https://curecurrent.com/trials/guided-meditation-during-radiation-therapy-for-breast-and-gynecological-malignancies-28740https://curecurrent.com/trials/expanded-access-to-immunomodulatory-avm0703-for-solid-tumor-and-blood-cancer-patients-28741https://curecurrent.com/trials/national-mammography-database-28742https://curecurrent.com/trials/anti-ny-eso-1-tcr-gene-engineered-lymphocytes-given-by-infusion-to-patients-with-ny-eso-1-expressing-metastatic-cancers-28743https://curecurrent.com/trials/fear-of-cancer-recurrence-therapy-fort-turkish-cultural-adaptation-and-implementation-project-28744https://curecurrent.com/trials/rjbc-app-and-breast-cancer-treatment-compliance-28745https://curecurrent.com/trials/exercise-to-improve-neurovascular-function-in-breast-cancer-survivors-28746https://curecurrent.com/trials/autologous-and-allogeneic-whole-cell-cancer-vaccine-for-metastatic-tumors-28747https://curecurrent.com/trials/effectiveness-of-ultrasound-guided-pecs-block-on-opioid-consumption-and-patient-satisfaction-through-adequate-pain-contr-28748https://curecurrent.com/trials/proactive-study-evaluation-of-the-impact-of-a-multidimensional-geriatric-intervention-program-28749https://curecurrent.com/trials/the-effect-of-360-virtual-reality-movies-on-fear-and-anxiety-28750https://curecurrent.com/trials/high-intensity-focused-ultrasound-treatment-of-breast-tumors-brifu-study-28751https://curecurrent.com/trials/tusamitamab-ravtansine-monotherapy-and-in-combination-in-patients-with-ceacam5-positive-advanced-solid-tumors-28752https://curecurrent.com/trials/testing-the-addition-of-an-anti-cancer-drug-copanlisib-to-the-usual-maintenance-treatment-trastuzumab-and-pertuzumab-aft-28753https://curecurrent.com/trials/short-term-impacts-of-endocrine-therapy-on-cardiovascular-and-brain-health-outcomes-in-breast-cancer-28754https://curecurrent.com/trials/all-extremity-exercise-during-breast-cancer-chemotherapy-28755https://curecurrent.com/trials/time-restricted-eating-during-chemotherapy-for-breast-cancer-28756https://curecurrent.com/trials/multiple-risk-factor-intervention-trial-in-breast-cancer-survivors-28757https://curecurrent.com/trials/care-chemotherapy-alopecia-reduction-28758https://curecurrent.com/trials/dv-in-combination-with-pertuzumab-with-or-without-toripalimab-neoadjuvant-therapy-with-her2-positive-breast-cancer-28759https://curecurrent.com/trials/cardio-oncology-rehabilitation-exercise-28760https://curecurrent.com/trials/radiofrequency-of-breast-cancers-in-non-surgical-patients-28761https://curecurrent.com/trials/efficacy-verification-in-early-diagnosis-and-management-of-lymphedema-through-home-body-water-analyzer-28762https://curecurrent.com/trials/natriuretic-peptide-concentrations-of-b-type-bnp-during-anesthesia-in-patients-previously-sensitized-to-anthracyclines-28763https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetic-behavior-of-leuprolide-injectable-emulsion-for-premenopausal-breast-cancer-subjects-28764https://curecurrent.com/trials/a-first-in-human-phase-1-safety-and-biodistribution-of-177lu-lu-aby-271-in-subjects-with-her2-positive-metastatic-breast-28765https://curecurrent.com/trials/remote-time-restricted-eating-delivery-28766https://curecurrent.com/trials/adjuvant-pvx-410-vaccine-and-durvalumab-in-stage-ii-iii-triple-negative-breast-cancer-28767https://curecurrent.com/trials/a-multi-modality-surveillance-program-for-women-at-high-risk-for-breast-cancer-28768https://curecurrent.com/trials/prevention-of-doxorubicin-induced-cardiotoxicity-in-breast-cancer-patients-28769https://curecurrent.com/trials/a-prospective-single-center-phase-ii-study-of-sacituzumab-tirumotecan-in-combination-with-pembrolizumab-for-neoadjuvant-28770https://curecurrent.com/trials/primary-prevention-of-thrombocytopenia-associated-with-t-dm1-therapy-in-her2-positive-breast-cancer-with-herombopag-28771https://curecurrent.com/trials/web-based-intervention-for-long-term-breast-cancer-survivors-28772https://curecurrent.com/trials/immune-adverse-events-registry-in-onco-hematologic-patients-treated-with-immunotherapy-28773https://curecurrent.com/trials/meliora-data-collection-campaigns-28774https://curecurrent.com/trials/the-fyi-on-mri-a-multilevel-decision-support-intervention-for-screening-breast-mri-28775https://curecurrent.com/trials/cisplatin-vs-paclitaxel-for-triple-negative-breast-cancer-28776https://curecurrent.com/trials/study-of-ac699-in-patients-with-estrogen-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-er-her2-loc-28777https://curecurrent.com/trials/study-of-metabolites-markers-in-adjuvant-breast-cancer-28778https://curecurrent.com/trials/evaluating-the-effectiveness-of-an-individualized-nutrition-and-physical-activity-counseling-program-28779https://curecurrent.com/trials/adjuvant-abemaciclib-for-locoregional-recurrence-of-hr-positive-her2-negative-breast-cancer-jcog2313-aura-28780https://curecurrent.com/trials/impact-of-topical-tranexamic-acid-in-breast-reconstruction-28781https://curecurrent.com/trials/comparison-of-outcomes-of-right-internal-jugular-port-implantation-in-patients-with-right-versus-left-breast-cancer-unde-28782https://curecurrent.com/trials/sacituzumab-govitecan-and-intrathecal-chemotherapy-for-treating-leptomeningeal-metastases-from-her2-negative-breast-canc-28783https://curecurrent.com/trials/exercise-in-targeting-metabolic-dysregulation-in-stage-i-iii-breast-or-prostate-cancer-survivors-28784https://curecurrent.com/trials/phase-ii-multi-center-trial-evaluating-5-fraction-stereotactic-partial-breast-irradiation-using-gammapod-28785https://curecurrent.com/trials/a-phase-ii-exploratory-study-of-iparomlimab-and-tuvonralimab-combined-with-chemotherapy-in-neoadjuvant-treatment-of-hr-h-28786https://curecurrent.com/trials/a-study-to-compare-eribulin-mesylate-pertuzumab-trastuzumab-with-paclitaxel-or-docetaxel-pertuzumab-trastuzumab-28787https://curecurrent.com/trials/a-study-of-si-b003-a-pd-1-ctla-4-bispecific-antibody-in-patients-with-advanced-solid-tumors-28788https://curecurrent.com/trials/a-study-of-si-b003-or-bl-b01d1-si-b003-in-patients-with-unresectable-locally-advanced-or-recurrent-metastatic-her2-negat-28789https://curecurrent.com/trials/online-patient-navigation-program-for-patients-with-breast-cancer-28790https://curecurrent.com/trials/a-study-of-gnc-035-a-tetra-specific-antibody-in-participants-with-locally-advanced-or-metastatic-breast-cancer-28791https://curecurrent.com/trials/preoperative-palbociclib-in-patients-with-dcis-of-the-breast-that-are-candidates-for-surgery-28792https://curecurrent.com/trials/analyses-of-exosomes-in-the-cerebrospinal-fluid-for-breast-cancer-patients-with-suspicion-of-leptomeningeal-metastasis-28793https://curecurrent.com/trials/a-study-of-bl-m02d1-in-patients-with-locally-advanced-or-metastatic-triple-negative-breast-cancer-or-other-solid-tumors-28794https://curecurrent.com/trials/arv-471-in-combination-with-everolimus-for-the-treatment-of-advanced-or-metastatic-er-her2-breast-cancer-28795https://curecurrent.com/trials/abemaciclib-in-combination-with-endocrine-therapy-as-first-line-therapy-in-metastatic-breast-cancer-patients-28796https://curecurrent.com/trials/adjuvant-trastuzumab-plus-neratinib-in-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-positive-breas-28797https://curecurrent.com/trials/neoadjuvant-lenvatinib-combined-with-letrozole-in-hormone-receptor-positive-breast-cancer-28798https://curecurrent.com/trials/a-study-with-nkt3447-for-adults-with-advanced-metastatic-solid-tumors-28799https://curecurrent.com/trials/efficacy-study-of-ifabond-in-breast-cancer-surgery-28800https://curecurrent.com/trials/a-study-of-gr1014-cutaneous-gel-for-the-prevention-of-skin-reactions-caused-by-radiation-therapy-for-breast-cancer-28801https://curecurrent.com/trials/phase-ii-study-of-dato-dxd-in-triple-negative-breast-cancer-patients-with-newly-diagnosed-or-progressing-brain-metastase-28802https://curecurrent.com/trials/a-single-arm-phase-ib-ii-trial-of-single-agent-pacritinib-in-patients-with-1q21-3-amplified-solid-tumors-enriching-for-i-28803https://curecurrent.com/trials/treatment-of-refractory-nausea-and-vomiting-in-patients-with-breast-cancer-28804https://curecurrent.com/trials/acupuncture-for-anxiety-depression-in-patients-with-breast-cancer-28805https://curecurrent.com/trials/a-study-of-invikafusp-alfa-star0602-a-selective-t-cell-receptor-tcr-targeting-bifunctional-antibody-fusion-molecule-in-c-28806https://curecurrent.com/trials/pyrotinib-maleate-tablets-in-combination-with-dalpiciclib-isethionate-tablets-and-standard-endocrine-therapy-28807https://curecurrent.com/trials/rhomboid-intercostal-plane-block-on-chronic-pain-incidence-and-acute-pain-scores-after-mastectomy-28808https://curecurrent.com/trials/development-of-a-new-remote-monitoring-model-for-patients-with-hr-her2-breast-cancer-in-treatment-with-cdk4-6-inhibitors-28809https://curecurrent.com/trials/sms-messaging-as-a-tool-to-improve-cancer-screening-programs-28810https://curecurrent.com/trials/clinical-study-of-chemotherapy-and-immunotherapy-combined-with-lactobacillus-johnsonii-in-patients-with-multiple-irresec-28811https://curecurrent.com/trials/enhancing-cancer-prevention-and-control-pathways-native-health-initiative-28812https://curecurrent.com/trials/study-to-determine-absorption-metabolism-and-excretion-of-14c-sar439859-and-to-assess-absolute-oral-bioavailability-of-a-28813https://curecurrent.com/trials/a-study-to-evaluate-trop2-adc-lcb84-single-agent-and-in-combination-with-an-anti-pd-1-ab-in-advanced-solid-tumors-28814https://curecurrent.com/trials/18f-fdg-versus-68ga-fapi-46-as-pet-tracer-in-er-positive-breast-cancer-28815https://curecurrent.com/trials/ai-based-pcr-assessment-prediction-in-her2-positive-bc-using-pet-mri-28816https://curecurrent.com/trials/identification-of-her2-positive-breast-cancer-molecular-characterization-and-subtypes-28817https://curecurrent.com/trials/predicting-breast-cancer-response-to-neoadjuvant-therapy-by-ctdna-assessment-28818https://curecurrent.com/trials/optimizing-and-personalising-azacitidine-combination-therapy-for-treating-solid-tumours-qpop-and-curate-ai-28819https://curecurrent.com/trials/the-neoadjuvant-treatment-of-early-high-risk-triple-negative-breast-cancer-with-hrd-positive-with-iparomlimab-and-tuvonr-28820https://curecurrent.com/trials/chimeric-receptor-t-cells-with-trastuzumab-in-her2-advanced-breast-cancer-and-other-solid-tumors-28821https://curecurrent.com/trials/her2-treat-study-retrospective-study-to-estimate-the-prevalence-of-her2-low-in-unresectable-and-or-metastatic-breast-can-28822https://curecurrent.com/trials/bergonie-institute-breast-cancer-database-28823https://curecurrent.com/trials/family-based-intervention-study-of-the-effects-of-environmental-exposures-on-breast-tissue-composition-28824https://curecurrent.com/trials/phase-ii-study-of-ftd-tpi-lonsurf-in-metastatic-breast-cancers-with-or-without-prior-exposure-to-fluoropyrimidines-lonbr-28825https://curecurrent.com/trials/mechanistic-study-of-sparc-mediated-regulation-of-neutrophil-extracellular-trap-formation-in-the-brain-metastatic-microe-28826https://curecurrent.com/trials/individuals-on-hormone-therapy-breast-cancer-screening-pilot-28827https://curecurrent.com/trials/effect-of-dexmedetomidine-infusion-on-post-anesthesia-discharge-time-28828https://curecurrent.com/trials/the-role-of-bexarotene-in-inducing-susceptibility-to-chemotherapy-in-metastatic-tnbc-28829https://curecurrent.com/trials/correlation-between-covid-19-and-radiation-pneumonitis-in-breast-cancer-28830https://curecurrent.com/trials/a-phase-iii-study-of-esg401-for-unresectable-recurrent-or-metastatic-triple-negative-breast-cancer-28831https://curecurrent.com/trials/evaluation-of-the-subjectively-perceived-pelvic-floor-function-in-patients-with-gynecological-tumors-and-breast-cancer-u-28832https://curecurrent.com/trials/cardiotoxicity-in-breast-cancer-patients-28833https://curecurrent.com/trials/neurocognitive-and-psychological-impact-of-chemotherapy-in-breast-cancer-patients-a-prospective-observational-study-28834https://curecurrent.com/trials/physical-exercise-during-preoperative-chemotherapy-for-breast-cancer-28835https://curecurrent.com/trials/single-stage-prepectoral-placement-of-textured-implants-using-a-polyester-mesh-endoprostheses-with-fluoropolymer-coating-28836https://curecurrent.com/trials/first-in-human-study-of-mutant-selective-pi3k-inhibitor-rly-2608-as-a-single-agent-in-patients-with-advanced-solid-tumor-28837https://curecurrent.com/trials/isolation-of-volatile-organic-compounds-vocs-related-to-the-olfactory-signature-of-breast-cancer-kdogcov-28838https://curecurrent.com/trials/recurindex-guided-avoidance-of-regional-nodal-irradiation-for-node-positive-breast-cancer-28839https://curecurrent.com/trials/chlorhydrate-of-ropivacaine-and-breast-cancer-surgery-28840https://curecurrent.com/trials/evaluation-of-the-medidux-digital-health-application-in-patients-with-her2-positive-breast-cancer-28841https://curecurrent.com/trials/intensity-modulated-accelerated-partial-breast-irradiation-before-surgery-in-treating-older-patients-with-hormone-respon-28842https://curecurrent.com/trials/a-study-of-allogenic-natural-killer-cells-in-combination-with-trastuzumab-and-pertuzumab-in-adult-patients-with-refracto-28843https://curecurrent.com/trials/hydrosorb-versus-control-in-the-management-of-radio-induced-skin-toxicity-multicentre-controlled-phase-iii-randomized-tr-28844https://curecurrent.com/trials/mirs-04-interpectoral-nerve-block-with-ropivacaine-versus-placebo-before-breast-cancer-surgery-28845https://curecurrent.com/trials/communicating-with-patients-on-cancer-resistance-to-treatment-the-development-of-a-communication-tool-hector-28846https://curecurrent.com/trials/trudi-tdxd-durva-in-her2-low-ibc-28847https://curecurrent.com/trials/from-exclusion-to-inclusion-analysing-follow-up-discontinuity-in-breast-cancer-28848https://curecurrent.com/trials/administration-of-ketamine-to-prevent-the-post-operative-pain-28849https://curecurrent.com/trials/er-one-a-double-blind-trial-of-erector-spinae-block-esp-versus-paravertebral-block-pvb-before-breast-cancer-surgery-28850https://curecurrent.com/trials/remotely-supervised-computerized-cognitive-stimulation-to-reduce-post-chemotherapy-cognitive-difficulties-in-patients-tr-28851https://curecurrent.com/trials/improving-care-after-inherited-cancer-testing-28852https://curecurrent.com/trials/piloting-18f-fapi-pet-mri-for-applications-in-breast-cancer-28853https://curecurrent.com/trials/a-study-of-disappearing-markers-for-daily-radiation-treatment-delivery-for-breast-cancer-patients-28854https://curecurrent.com/trials/examining-personalised-radiation-therapy-for-low-risk-early-breast-cancer-28855https://curecurrent.com/trials/nis-study-determining-prevalence-of-her2-low-in-metastatic-breast-cancer-patients-28856https://curecurrent.com/trials/phase-2-window-study-of-sar439859-amcenestrant-versus-letrozole-in-post-menopausal-patients-with-er-her2-pre-operative-p-28857https://curecurrent.com/trials/a-study-of-bl-b16d1-in-patients-with-unresectable-locally-advanced-or-metastatic-breast-cancer-and-other-solid-tumors-28858https://curecurrent.com/trials/study-of-sacituzumab-govitecan-hziy-and-pembrolizumab-versus-treatment-of-physician-s-choice-and-pembrolizumab-in-patien-28859https://curecurrent.com/trials/unfold-study-egypt-28860https://curecurrent.com/trials/effectiveness-of-a-therapeutic-exercise-program-with-specific-upper-limb-exercises-to-reduce-lymphedema-and-neuropathy-i-28861https://curecurrent.com/trials/maintenance-therapy-in-her2-positive-unresectable-locally-recurrent-or-metastatic-breast-cancer-a-phase-ii-study-28862https://curecurrent.com/trials/a-real-world-study-on-the-compliance-of-ofs-assisted-endocrine-therapy-for-hormone-receptor-positive-hr-premenopausal-br-28863https://curecurrent.com/trials/contrast-enhanced-mammography-for-breast-cancer-staging-in-patients-referred-for-a-second-opinion-28864https://curecurrent.com/trials/desir-evaluation-of-the-pre-therapeutic-activity-of-dihydropyrimidine-deshydrogenase-dpd-in-patients-with-cancer-and-or-28865https://curecurrent.com/trials/comparison-of-changes-in-the-quality-of-life-of-patients-operated-on-breast-cancer-at-the-dr-me-ard-che-breast-institute-28866https://curecurrent.com/trials/breast-reconstruction-and-radiotherapy-28867https://curecurrent.com/trials/lccc1931-post-treatment-intervention-in-women-with-breast-cancer-70y-o-28868https://curecurrent.com/trials/modi-1-moditope-in-breast-head-and-neck-ovarian-or-renal-cancer-28869https://curecurrent.com/trials/indocyanine-green-fluoroscopy-and-spy-angiography-for-the-assessment-of-lymphatic-structure-in-breast-cancer-patients-at-28870https://curecurrent.com/trials/study-of-jskn016-combination-therapy-in-inoperable-locally-advanced-or-metastatic-her2-negative-breast-cancer-28871https://curecurrent.com/trials/a-two-cohort-study-of-shr-a1811-in-the-treatment-of-her2-positive-breast-cancer-with-brain-metastases-28872https://curecurrent.com/trials/disitamab-vedotin-rc48-adc-in-breast-cancer-28873https://curecurrent.com/trials/study-of-amcenestrant-sar439859-versus-tamoxifen-for-patients-with-hormone-receptor-positive-hr-early-breast-cancer-who-28874https://curecurrent.com/trials/impact-of-recurrence-score-on-adjuvant-treatment-decisions-in-breast-cancer-patients-28875https://curecurrent.com/trials/feasibility-study-of-ablathermy-focused-ultrasound-usf-of-breast-tumors-before-mastectomy-28876https://curecurrent.com/trials/sweden-cancerome-analysis-network-breast-recurrence-scan-b-rec-28877https://curecurrent.com/trials/self-acupressure-and-zhan-zhuang-for-symptom-cluster-management-28878https://curecurrent.com/trials/a-trial-to-evaluate-sacituzumab-govitecan-in-combination-with-endocrine-therapy-in-patients-with-hr-positive-her2-negati-28879https://curecurrent.com/trials/gut-microbe-composition-exercise-and-breast-breast-cancer-survivors-28880https://curecurrent.com/trials/rifaximin-for-the-treatment-of-gastrointestinal-toxicities-related-to-pertuzumab-based-therapy-in-patients-with-stage-i-28881https://curecurrent.com/trials/omission-of-local-therapies-in-women-patients-with-her2-positive-or-triple-negative-breast-cancer-28882https://curecurrent.com/trials/integrated-actionable-aging-assessment-for-cancer-patients-pilot-28883https://curecurrent.com/trials/a-first-in-human-study-using-bdc-1001-as-a-single-agent-and-in-combination-with-nivolumab-in-advanced-her2-expressing-so-28884https://curecurrent.com/trials/dose-escalation-and-expansion-study-of-sar443216-in-participants-with-relapsed-refractory-her2-expressing-solid-tumors-28885https://curecurrent.com/trials/fdg-pet-ct-in-advanced-breast-cancer-28886https://curecurrent.com/trials/phase-1-study-of-fs-1502-in-patients-with-her2-expressed-advanced-solid-tumors-and-breast-cancer-28887https://curecurrent.com/trials/radiofrequency-ablation-rfa-in-breast-tumors-28888https://curecurrent.com/trials/safety-and-efficacy-real-world-data-of-trastuzumab-deruxtecan-and-sacituzumab-govitecan-28889https://curecurrent.com/trials/a-phase-ib-ii-study-of-qlc1401-combined-with-cdk4-6-or-mtor-inhibitors-in-er-her2-advanced-breast-cancer-28890https://curecurrent.com/trials/augmented-virtual-reality-for-reducing-pain-stress-anxiety-and-improve-self-efficacy-in-adult-cancer-patients-undergoing-28891https://curecurrent.com/trials/efficacy-of-non-ablative-radiofrequency-combined-with-pelvic-floor-muscle-training-for-genitourinary-syndrome-of-menopau-28892https://curecurrent.com/trials/clinical-study-of-breast-conserving-surgery-combined-with-intraoperative-radiotherapy-for-early-breast-cancer-28893https://curecurrent.com/trials/tango-for-neuropathy-among-breast-cancer-survivors-28894https://curecurrent.com/trials/phase-3-trial-of-elacestrant-versus-standard-of-care-for-the-treatment-of-er-her2-advanced-breast-cancer-28895https://curecurrent.com/trials/study-of-esg401-in-adults-with-solid-tumors-28896https://curecurrent.com/trials/simple-surgical-glove-compression-to-prevent-chemotherapy-induced-peripheral-neuropathy-28897https://curecurrent.com/trials/a-study-of-yl202-in-combination-with-other-anti-tumor-therapies-in-patients-with-advanced-solid-tumors-28898https://curecurrent.com/trials/myofascial-pain-syndrome-in-patients-with-breast-cancer-related-lymphedema-28899https://curecurrent.com/trials/study-of-immunotherapy-in-combination-with-chemotherapy-in-her2-negative-inflammatory-breast-cancer-28900https://curecurrent.com/trials/nordictrip-a-translational-study-of-preoperative-chemotherapy-in-tnbc-28901https://curecurrent.com/trials/effect-of-metformin-on-endometrial-thickness-in-postmenopausal-breast-cancer-patients-receiving-tamoxifen-28902https://curecurrent.com/trials/management-of-ductal-carcinoma-in-situ-or-pure-micro-invasive-extended-breast-28903https://curecurrent.com/trials/a-study-to-evaluate-ethanol-induced-symptoms-and-safety-in-breast-cancer-patients-28904https://curecurrent.com/trials/feasibility-acceptability-and-preliminary-efficacy-of-the-new-iteration-of-the-innovative-smartphone-based-care-solution-28905https://curecurrent.com/trials/jskn003-versus-treatment-of-physician-s-choice-for-her2-low-unresectable-and-or-metastatic-breast-cancer-subjects-28906https://curecurrent.com/trials/breast-cancer-ai-imaging-study-28907https://curecurrent.com/trials/a-study-of-treatment-related-toxicities-and-quality-of-life-after-local-therapy-in-chinese-breast-cancer-patients-28908https://curecurrent.com/trials/phase-3-study-randomized-evaluating-the-efficacy-of-auriculotherapy-in-patients-with-musculoskeletal-pain-by-aromatase-i-28909https://curecurrent.com/trials/effect-of-aromatase-inhibitors-on-ultrasonographic-measurements-and-static-and-dynamic-balance-scores-in-breast-cancer-28910https://curecurrent.com/trials/psychological-and-social-factors-and-risk-chronic-pain-after-surgery-in-women-with-breast-cancer-28911https://curecurrent.com/trials/adjuvant-study-of-pyrotinib-in-her-2-positive-breast-cancer-28912https://curecurrent.com/trials/sc-101-in-subjects-with-advanced-nectin4-amplified-cancers-28913https://curecurrent.com/trials/nab-paclitaxel-plus-carboplatin-versus-nab-paclitaxel-plus-capecitabine-in-the-treatment-of-advanced-triple-negative-bre-28914https://curecurrent.com/trials/digital-tool-for-psychological-support-in-women-with-breast-cancer-28915https://curecurrent.com/trials/cancer-health-assessments-reaching-many-28916https://curecurrent.com/trials/neoadjuvant-study-of-pyrotinib-in-her-2-positive-breast-cancer-28917https://curecurrent.com/trials/efficacy-and-safety-of-dalpiciclib-in-hormone-receptor-positive-advanced-breast-cancer-28918https://curecurrent.com/trials/effects-of-prolonged-continuous-theta-burst-stimulation-in-chemotherapy-induced-peripheral-neuropathy-28919https://curecurrent.com/trials/amcenestrant-sar439859-plus-palbociclib-as-first-line-therapy-for-patients-with-er-her2-advanced-breast-cancer-28920https://curecurrent.com/trials/nab-paclitaxel-plus-carboplatin-versus-nab-paclitaxel-plus-epirubicin-in-the-neoadjuvant-therapy-for-breast-cancer-28921https://curecurrent.com/trials/a-prospective-cohort-with-patient-navigation-as-an-intervention-for-breast-cancer-patients-28922https://curecurrent.com/trials/interest-of-broadband-spectroscopy-analysis-by-infrared-laser-on-liquid-biopsies-in-breast-cancer-screening-28923https://curecurrent.com/trials/a-clinical-trial-to-compare-efficacy-and-tolerability-of-atorvastatin-in-addition-to-endocrine-treatment-with-focus-on-m-28924https://curecurrent.com/trials/biological-matrices-versus-synthetic-meshes-28925https://curecurrent.com/trials/effects-of-physical-exercise-on-response-to-treatement-in-breast-cancer-28926https://curecurrent.com/trials/percist-evaluation-of-trastuzumab-deruxtecan-in-the-treatment-of-her2-low-breast-cancer-28927https://curecurrent.com/trials/factors-associated-with-health-related-quality-of-life-in-patients-with-breast-cancer-related-lymphedema-undergoing-pros-28928https://curecurrent.com/trials/neoadjuvant-chemotherapy-combined-with-preoperative-radiotherapy-for-locally-advanced-breast-cancer-28929https://curecurrent.com/trials/phase-ii-study-to-assess-the-efficacy-of-aslan001-plus-capecitabine-in-cns-metastases-for-her2-breast-cancer-28930https://curecurrent.com/trials/efficacy-of-neoadjuvant-subcutaneous-trastuzumab-pertuzumab-in-algerian-women-with-locally-advanced-her2-positive-breast-28931https://curecurrent.com/trials/a-trial-for-a-preliminary-estimate-of-the-effectiveness-of-a-novel-theoretical-framework-28932https://curecurrent.com/trials/evaluation-of-mobiderm-intimate-bra-in-the-management-of-breast-edema-related-to-breast-cancer-treatment-28933https://curecurrent.com/trials/a-phase-iii-trial-of-pertuzumab-retreatment-in-previously-pertuzumab-treated-her2-positive-advanced-breast-cancer-28934https://curecurrent.com/trials/cohort-study-on-sequential-adc-therapy-in-hr-positive-her2-negative-advanced-breast-cancer-28935https://curecurrent.com/trials/leronlimab-pro-140-combined-with-carboplatin-in-patients-with-cytokine-chemokine-receptor-5-positive-ccr5-mtnbc-28936https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-a2b395-an-allogeneic-logic-gated-car-t-in-participants-with-solid-tumors-28937https://curecurrent.com/trials/pre-analytical-factors-affecting-ctdna-analysis-in-early-and-locally-advanced-breast-cancer-28938https://curecurrent.com/trials/effect-of-cyclosporine-drug-interaction-on-the-absorption-metabolism-and-elimination-of-chf6001-in-healthy-volunteers-dr-28939https://curecurrent.com/trials/romiplostim-n01-in-the-treatment-of-thrombocytopenia-caused-by-cytotoxic-drugs-in-breast-cancer-patients-28940https://curecurrent.com/trials/study-with-atezolizumab-in-combination-with-trastuzumab-and-vinorelbine-in-her2-positive-advanced-metastatic-breast-canc-28941https://curecurrent.com/trials/combination-of-talimogene-laherparepvec-with-atezolizumab-in-early-breast-cancer-28942https://curecurrent.com/trials/stereotactic-body-radiation-therapy-for-breast-cancer-28943https://curecurrent.com/trials/adaptive-symptom-care-using-fish-based-nutritional-directives-post-breast-cancer-28944https://curecurrent.com/trials/camrelizumab-pirfenidone-and-chemotherapy-in-the-treatment-of-advanced-triple-negative-breast-cancer-28945https://curecurrent.com/trials/grouping-immune-modulation-with-cryoablation-logic-for-breast-cancers-28946https://curecurrent.com/trials/clinical-outcome-of-extracorporeal-shock-wave-therapy-in-patient-with-axillary-web-syndrome-28947https://curecurrent.com/trials/factors-affecting-rehabilitation-time-for-postoperative-complications-among-breast-cancer-patients-28948https://curecurrent.com/trials/zte-mri-pulse-sequence-use-for-visualization-of-bone-cement-breast-biopsy-markers-28949https://curecurrent.com/trials/a-study-of-nx-1607-in-adults-with-advanced-malignancies-28950https://curecurrent.com/trials/dragon-boat-race-versus-family-unsupervised-training-to-improve-the-physical-function-and-quality-of-life-in-breast-canc-28951https://curecurrent.com/trials/the-effect-of-interpersonal-relationships-psychotherapy-on-breast-cancer-patients-28952https://curecurrent.com/trials/quality-of-life-after-breast-cancer-surgery-28953https://curecurrent.com/trials/frailty-and-health-related-quality-of-life-in-older-women-with-breast-carcinoma-28954https://curecurrent.com/trials/comparing-quality-of-recovery-between-espb-and-iv-lidocaine-after-major-breast-cancer-surgery-28955https://curecurrent.com/trials/randomized-controlled-clinical-study-on-the-reduction-of-tumor-marker-levels-in-breast-cancer-patients-by-huaier-granule-28956https://curecurrent.com/trials/clinical-validation-of-sophia-genetics-assay-28957https://curecurrent.com/trials/a-feasibility-study-to-identify-t-cell-responses-to-neo-epitopes-in-tumor-invaded-lymph-nodes-neoepitope-28958https://curecurrent.com/trials/trastuzumab-alpelisib-fulvestrant-vs-trastuzumab-ct-in-patients-with-pik3ca-mutated-previously-treated-her2-advanced-bre-28959https://curecurrent.com/trials/a-study-of-sacituzumab-govitecan-plus-toripalimab-versus-toripalimab-plus-nab-paclitaxel-in-pd-l1-positive-advanced-tnbc-28960https://curecurrent.com/trials/a-post-treatment-program-to-identify-and-manage-complications-related-to-oncology-or-hematology-treatments-in-cancer-sur-28961https://curecurrent.com/trials/a-phase-1-study-of-xl309-ism3091-alone-and-in-combination-in-participants-with-advanced-solid-tumors-28962https://curecurrent.com/trials/breast-cancer-exercise-intervention-study-28963https://curecurrent.com/trials/digitally-distributed-yoga-for-women-treated-for-breast-cancer-28964https://curecurrent.com/trials/study-of-syn818-with-olaparib-for-the-treatment-of-locally-advanced-or-metastatic-solid-tumors-28965https://curecurrent.com/trials/sacituzumab-tirumotecan-plus-tagitanlimab-in-previously-treated-locally-advanced-or-metastatic-triple-negative-breast-ca-28966https://curecurrent.com/trials/socio-aesthetic-intervention-on-body-image-and-quality-of-life-in-women-with-breast-cancer-28967https://curecurrent.com/trials/a-study-of-tak-676-with-pembrolizumab-after-radiation-therapy-to-treat-a-number-of-cancers-28968https://curecurrent.com/trials/comparison-of-the-effects-of-general-anesthesia-and-pecs-block-methods-on-blood-counts-in-patients-with-breast-cancer-28969https://curecurrent.com/trials/assessment-the-sexual-quality-of-life-in-breast-cancer-patients-receiving-oncosexology-supportive-care-on-proactive-vers-28970https://curecurrent.com/trials/development-and-usability-evaluation-of-an-arm-circumference-measurement-tool-for-patients-undergoing-breast-surgery-28971https://curecurrent.com/trials/rapid-assessment-of-sentinel-lymph-node-metastasis-status-using-a-pan-ck-targeting-nir-ii-fluorescent-probe-in-breast-ca-28972https://curecurrent.com/trials/de-escalation-therapy-in-stage-i-er-positive-breast-cancer-a-non-inferiority-trial-28973https://curecurrent.com/trials/a-study-to-investigate-the-pharmacokinetics-of-midazolam-after-repeated-doses-of-camizestrant-azd9833-and-to-investigate-28974https://curecurrent.com/trials/breast-cancer-genome-guided-therapy-study-beauty-28975https://curecurrent.com/trials/effectiveness-of-kinesio-taping-in-patients-with-chronic-breast-and-or-truncal-oedema-after-treatment-for-breast-cancer-28976https://curecurrent.com/trials/fluorescence-imaging-of-carcinoma-during-breast-conserving-surgery-28977https://curecurrent.com/trials/real-world-study-in-the-adjuvant-setting-for-high-risk-early-breast-cancer-patients-28978https://curecurrent.com/trials/trastuzumab-deruxtecan-versus-standard-neoadjuvant-treatment-for-her2-positive-breast-cancer-28979https://curecurrent.com/trials/targeting-mdmd-and-pd1-in-tumors-with-tertiary-lymphoid-structures-28980https://curecurrent.com/trials/tdcs-intervention-in-breast-cancer-survivors-with-and-without-obesity-reporting-cognitive-impairment-28981https://curecurrent.com/trials/efficacy-and-safety-study-of-enzalutamide-in-combination-with-exemestane-in-patients-with-advanced-breast-cancer-28982https://curecurrent.com/trials/the-effects-of-anthracycline-based-chemotherapy-on-peripheral-vascular-function-28983https://curecurrent.com/trials/microvascular-function-in-patients-undergoing-5-fluorouracil-chemotherapy-28984https://curecurrent.com/trials/fdg-pet-ct-in-breast-cancer-bone-mets-28985https://curecurrent.com/trials/health-belief-model-based-survey-on-breast-self-examination-awareness-and-practice-among-community-dwelling-middle-aged-28986https://curecurrent.com/trials/impact-of-aerobic-exercise-on-the-anticancer-immune-response-in-patients-receiving-cancer-treatment-28987https://curecurrent.com/trials/a-trial-using-arv-471-or-anastrozole-in-post-menopausal-women-with-breast-cancer-prior-to-surgery-28988https://curecurrent.com/trials/tucatinib-trastuzumab-and-capecitabine-for-the-treatment-of-her2-lmd-28989https://curecurrent.com/trials/exclusive-endocrine-therapy-or-radiation-therapy-for-women-aged-70-years-early-stage-breast-cancer-28990https://curecurrent.com/trials/tactic-taa-specific-cytotoxic-t-lymphocytes-in-patients-with-breast-cancer-28991https://curecurrent.com/trials/a-study-of-real-world-outcomes-among-patients-treated-with-ribociclib-28992https://curecurrent.com/trials/evaluation-of-a-novel-technique-for-the-discovery-of-new-tumor-specific-targets-for-the-deployment-of-innovative-immunot-28993https://curecurrent.com/trials/a-study-of-ad-rts-hil-12-with-veledimex-in-subjects-with-breast-cancer-28994https://curecurrent.com/trials/prehabilitation-to-revolutionize-oncology-telehealth-exercise-for-cognitive-triumphs-the-protect-trial-28995https://curecurrent.com/trials/prevention-of-sacituzumab-govitecan-related-neutropenia-in-patients-with-metastatic-triple-negative-breast-cancer-28996https://curecurrent.com/trials/targeted-nerve-surgery-for-the-prevention-of-post-mastectomy-pain-syndrome-a-randomized-trial-28997https://curecurrent.com/trials/adenoviral-vector-monotherapy-or-combination-with-chemotherapy-in-subjects-with-recurrent-metastatic-breast-cancer-28998https://curecurrent.com/trials/brave-strategy-breast-cancer-risk-assessment-achieving-equity-28999https://curecurrent.com/trials/pathways-to-advance-targeted-and-helpful-serious-illness-conversations-path-sic-29000